{
  "name" : "twin.sci-hub.se_5939_de136f077e64972eb4498b04cfaa52f4_zhang2016.pdf",
  "metadata" : {
    "source" : "CRF",
    "title" : null,
    "authors" : [ "Zhang Yong Cui", "Lili Li", "Feng Shi", "Nianqiu Li", "Chunlei Yu", "Xianghui Chen", "Yan Kong Wei", "Zhang Yong", "Li Feng", "Shi Nianqiu", "Li Chunlei", "Yu Xianghui" ],
    "emails" : [ "zhangyongking1@gmail.com;", "chen_yan@jlu.edu.cn" ],
    "sections" : [ {
      "heading" : null,
      "text" : "Accepted Manuscript\nTitle: Design, fabrication and biomedical applications of zein-based nano/micro-carrier systems Author: Zhang Yong Cui Lili Li Feng Shi Nianqiu Li Chunlei Yu Xianghui Chen Yan Kong Wei PII: S0378-5173(16)30844-4 DOI: http://dx.doi.org/doi:10.1016/j.ijpharm.2016.09.023 Reference: IJP 16065 To appear in: International Journal of Pharmaceutics Received date: 11-7-2016 Revised date: 5-9-2016 Accepted date: 7-9-2016 Please cite this article as: Zhang, Yong, Cui, Lili, Li, Feng, Shi, Nianqiu, Li, Chunlei, Yu, Xianghui, Chen, Yan, Kong, Wei, Design, fabrication and biomedical applications of zein-based nano/micro-carrier systems.International Journal of Pharmaceutics http://dx.doi.org/10.1016/j.ijpharm.2016.09.023 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.\nTitle Design, fabrication and biomedical applications of zein-based nano/micro-carrier systems\nAuthors Zhang Yong a,b,c,* , Cui Lili d , Li Feng a , Shi Nianqiu b,e , Li Chunlei c , Yu Xianghui a,b , Chen Yan a,b,* , Kong Wei a,b Affiliations a National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China b Key Laboratory for Molecular Enzymology and Engineering, the Ministry of Education, School of Life Sciences, Jilin University, Changchun 130012, China c State Key Laboratory of New Pharmaceutical Preparations and Excipients, Shijiazhuang 050051, China d Pharmaceutical Biophysics Group, Institute of Pharmaceutical Science, King‘s College London, 150 Stamford Street, London SE1 9NH, United Kingdom e Department of Pharmaceutics, School of Pharmacy, Jilin Medical University, Jilin 132013, China. *Correspondences: Zhang Yong and Chen Yan School of Life Sciences, Jilin University, Qianjin Street No. 2699, Changchun 130012, China Tel: +86 431 85167751; Fax: +86 431 85167674 E-mail: zhangyongking1@gmail.com; chen_yan@jlu.edu.cn\nGraphical abstract Classes, size range of zein-based particles/capsules fabricated using various methods and their biomedical applications.\nAbstract Nano/micro-carrier systems have shown promising application in the biomedical field as various delivery carriers. The composite material and fabrication method determine their microstructures, properties and thus their potential applications. Since approved as tablet coating material by the U.S. Food and Drug Administration (US-FDA), zein has been widely investigated as one of protein-based materials in the past few decades. Zein is renewable, biodegradable and relatively inexpensive in comparison with animal proteins (e.g., gelatin and albumin). This paper reviews the current landscape of zein-based nano/micro-carrier systems, with particular emphasis on nano/microparticles, nano/microcapsules and their design, fabrication, assembly mechanisms and biomedical applications especially for controlled drug delivery. The benefits, challenges and related solutions of zein-based colloidal carrier systems are also discussed. In addition, investigations on the molecular structure, biocompatibility and immunogenicity of zein are summarized and discussed. Keywords: biopolymer; nano/microparticle; nanocapsule; microcapsule; delivery carrier\nContents 1. Introduction --------------------------------------------------------------------------------------- 3 2. Fundamental aspects of zein ------------------------------------------------------------------- 5\n2.1 Structure ------------------------------------------------------------------------------------ 5 2.2 Biocompatibility -------------------------------------------------------------------------- 7 2.3 Immunogenicity --------------------------------------------------------------------------- 9 3 Carrier classes and morphologies------------------------------------------------------------- 10\n3.1 Nano/microparticles --------------------------------------------------------------------- 11 3.2 Nano/microcapsules --------------------------------------------------------------------- 12\n3.3 Micelles ------------------------------------------------------------------------------------ 13 3.4 Zein-stabilized Pickering emulsions -------------------------------------------------- 14 4 Preparation methods ---------------------------------------------------------------------------- 15\n4.1 Chemical crosslinking ------------------------------------------------------------------- 15 4.2 Emulsification/solvent evaporation---------------------------------------------------- 17 4.3 Emulsification/precipitation/gelation ------------------------------------------------- 18 4.4 Spray drying ------------------------------------------------------------------------------ 19 4.5 Supercritical anti-solvent technique --------------------------------------------------- 21 4.6 Phase separation -------------------------------------------------------------------------- 22 5 Challenges and solutions----------------------------------------------------------------------- 26\n5.1 pH adjustment ---------------------------------------------------------------------------- 26 5.2 Stabilizers --------------------------------------------------------------------------------- 27 5.3 Buffering agents and lyoprotectants --------------------------------------------------- 28 6 Biomedical applications ----------------------------------------------------------------------- 31\n6.1 Controlled release ----------------------------------------------------------------------- 31\n6.1.1 Crosslinked microparticles -------------------------------------------------------- 32 6.1.2 Complex microparticles ----------------------------------------------------------- 33 6.1.3 Tableted microparticles ------------------------------------------------------------ 34 6.1.4 Coated nanoparticles --------------------------------------------------------------- 36 6.2 Improved stability ----------------------------------------------------------------------- 37 6.3 Targeted delivery ------------------------------------------------------------------------ 38 6.4 Improved cellular uptake and oral bioavailability ---------------------------------- 39 7 Conclusions and perspectives ----------------------------------------------------------------- 40\nAcknowledgements ---------------------------------------------------------------------------- 43 References --------------------------------------------------------------------------------------- 43"
    }, {
      "heading" : "1. Introduction",
      "text" : "Nano/micro-carrier systems have great advantages over other carriers in terms of robustness, small size, large surface area, versatile surface modification, intracellular uptake and controlled release (Karthikeyan et al., 2012; Luo et al., 2013a; Penalva et al.,\n2015; Xu et al., 2015; Zou and Gu, 2013). For these reasons, they display great potential in delivering therapeutic agents into the systemic circulation via invasive/non-invasive routes. Some preparations in the form of microparticles have already been used in clinical practice and have shown great improvement in patient compliance without negative effects on medical efficacy. For example, triptorelin-loaded microspheres (Lundstrom et al., 2009) and exendin-4-loaded microspheres (Ryan et al., 2013) approved by the US-FDA in 2010 and 2012 for the treatment of advanced prostate cancer and type 2 diabetes, respectively, can dramatically reduce injection frequency via sustained drug release. The composition and microstructure of carrier systems usually have a great influence on the in vivo behavior of carriers and thus their therapeutic efficacy. Various natural and synthetic polymers (e.g., chitosan, albumin, collagen and poly(lactic-co-glycolic acid) (PLGA)) have been investigated to illustrate their potential as nano/micro-carrier systems (Kratz, 2014; Masotti and Ortaggi, 2009; Mora-Huertas et al., 2010). Recently, plant-based proteins have emerged as novel biomaterials with the potential of drug and gene delivery (Reddy and Yang, 2011). Plant-based proteins are easily available and biodegradable. Many of them, such as zein, soybean and wheat proteins, have been consumed as an integral part of human diet. Zein was approved in 1985 by the US-FDA as a generally recognized as safe excipient for tablet and pellet coating (Anonymous, 1985). Zein is a family of alcohol-soluble prolamins isolated from corn (Gorham, 1821). According to solubility and sequence similarity, it is divided into 4 groups: α-zein (19 and 22 kDa), β-zein (14 kDa), γ-zein (16 and 27 kDa), δ-zein (10 kDa) (Esen, 1987; Thompson and Larkins, 1989). It should be noted, however, that these zein proteins may have different molecular weights when\ndifferent extraction methods are used. Among these 4 types, α-zein and γ-zein, respectively, comprise about 80% and 15% of the total fraction of zein mass (Wilson, 1991). Zein primarily consists of hydrophobic and neutral amino acids but also contains some polar amino acid residues (e.g., glutamine) (Coleman and Larkins, 1999). Thus, zein is soluble only in limited solvents such as aqueous alcohols and alkaline solution (John, 2002). Commercially available zein may contain fewer xanthophyll pigments, which therefore leads to its yellow color (Kale et al., 2007; Moros et al., 2002). Details of the amino acid composition, extraction and purification methods and physicochemical properties of zein can be found in other publications (John, 2002; Rishi and Munir, 2001). Over the past few decades, zein has been investigated as various carriers, such as nano/microparticles, nano/microcapsules, films, nanofibers, hydrogel and implants, for delivery of bioactive agents (Corradini et al., 2014; Paliwal and Palakurthi, 2014; Zhang et al., 2015a; Zhang et al., 2015b). This paper focuses on the current landscape of zein-based colloidal nano/micro-carrier systems with emphasis on their design, preparation, assembly mechanisms and biomedical applications. Moreover, the benefits, limitations and related solutions in both fabrication and applications are also discussed. Investigations on the molecular structure, biocompatibility and immunogenicity of zein are also reviewed and discussed."
    }, {
      "heading" : "2. Fundamental aspects of zein",
      "text" : ""
    }, {
      "heading" : "2.1 Structure",
      "text" : "The structure of zein is closely related to its physicochemical properties and the self-assembly mechanism of various zein-based colloidal carrier systems. Structural\nstudies on zein have mainly focused on α-zein and γ-zein, probably due to their high fractions in total zein mass. The primary and secondary structures of α-zein and γ-zein can be easily determined by various techniques (e.g., chromatography, circular dichroism, fourier transform infrared spectroscopy (FTIR) and nuclear magnetic resonance (NMR)). α-zein is reported to have a high α-helix content of 35-60%, which is varied with a number of factors such as temperature, pH and solvent compositions (Cabra et al., 2006; Forato et al., 2003). γ-zein contains 33% α-helix and 31% β-sheet in its physiological states (Bicudo et al., 2005). However, in the presence of reducing agent dithiothreitol, γ-zein displays an increased α-helix content of about 55% accompanied by a decrease in β-sheet content to 6% (Bicudo et al., 2008; Bicudo et al., 2005). Similar to α-zein, the secondary structure of γ-zein is also solvent dependent (Bicudo et al., 2008). Of note, the N-terminal part of γ-zein contains eight proline-rich repetitive sequences of PPPVHL, which can form an extended left-handed amphipathic helix (polyproline II conformation). This proline-rich hexapeptide is a type of cell-penetrating peptides, which could be used as a carrier to improve the cellular uptake of drugs and genes (Fernandez-Carneado et al., 2004). Several models for the tertiary structure of α-zein have been suggested. The first one is based on the repeat sequence units and α-helix content analysis of zein in methanol (Figure 1-a) (Argos et al., 1982). In this model, 9 adjacent and antiparallel helices formed a cylindrical surface capped by glutamine residues. This structure was stabilized by both van der Waals forces and intramolecular hydrogen bonding, and the polar glutamine residues allowed further intermolecular stacking into planes via side chain interactions. This model gives a globular assembly structure with a 2:1 axial ratio and is\ncontrary to the elongated asymmetric structure determined by various physical measurements (Tatham et al., 1993). In another study, according to small-angle X-ray scattering (SAXS) data on zein in 70% ethanol, Matsushima et al. suggested a ribbon-like model with a dimension of 13 × 1.2 × 3 nm and an axial ratio of about 6:1 (Figure 1-b), which also consists of 9-10 adjacent and topologically antiparallel helices (Matsushima et al., 1997). In this model, the large hydrophobic surface formed by the side chains projecting from the helices allowed intermolecular two-dimensional hydrophobic aggregation and thus significantly improved the structural stability of α-zein. The ribbon-like model has been widely used to explain the different reorientation of zein molecules on hydrophilic/hydrophobic surfaces and the self-assembly process of zein from single molecules to nanoparticles (Wang et al., 2008a; Wang and Padua, 2012). Furthermore, a hairpin model composed of a series of helical structures was proposed according to the NMR, SAXS and FTIR data (Figure 1-c) (Forato et al., 2004). Different from the above models, these helixes, joined by loops, sheets or turns, are arranged in an extended way, and therefore can fold back on themselves or extend in other ways under different solvent environments. This extended structure fits the dimension of 13 × 1.2 × 3 nm and is more stable. In addition, it explains why the molecules can form fibers in water. More recently, a model of three super helical structures was suggested, and each composed of three antiparallel helical segments linked by a glutamine-rich turn (Figure 1-d) (Momany et al., 2006). The relatively open super helical structure is based on the results of molecular dynamics simulations and is in agreement with most physical measurements. However, further investigation is required to prove or disprove its correctness. In addition, it is noteworthy that the tertiary structure of α-zein can be\ninfluenced by various factors such as solvents (Li et al., 2012)."
    }, {
      "heading" : "2.2 Biocompatibility",
      "text" : "Biocompatibility refers to the suitable host response capacity of a biomaterial during its in vitro or in vivo application (Michel et al., 2012). Obviously, biocompatibility evaluation is closely related to the routes of administration and the purpose of application. To date, the biocompatibility studies of zein have mainly focused on tissue engineering, and most of them are still limited to the in vitro cellular level. Zein in the form of film with/without surface treatment was reported to be compatible with NIH 3T3 mouse embryonic fibroblast cells, HL-7702 human liver cells and BEL-7402 human hepatoma cells regarding cell attachment, spreadability and proliferation (Dong et al., 2004; Sun et al., 2005; Wang et al., 2009). This cytocompatibility is comparable to that of Corning microplate and polylactic acid films and is better than that of collagen, polyhydroxybutyrate and copolymer poly (hydroxybutyrate-co-hydroxyvalerate) films (Dong et al., 2004; Sun et al., 2005). In addition, trypsin and collagenase-degraded zein fractions at certain concentrations are reported to improve the viability of HL-7702 cell (Sun et al., 2005). Interestingly, zein molecules were found to have molecule orientation-dependent cytocompatibility (Wang et al., 2008a). This controlled cytocompatibility is based on the fact that zein molecules can respond sensitively to the polar character of the surfaces and reorient themselves in different ways from aqueous alcohol solutions (Wang et al., 2004; Wang et al., 2008a). Zein adopted a high rising orientation on the hydrophilic surface created with 11-mercaptoundecanoic acid or 16-mercaptohexadecanoic acid (MHA), whereas a low-lying structure was observed on the hydrophobic surface created with\n1-octanethiol or 18-octadecanethiol (ODT), as demonstrated by atomic force microscopy analysis (Wang et al., 2004; Wang et al., 2008a). The high rising structure was relatively hydrophilic, which probably corresponded with the region of glutamine loops of zein molecules, whereas the low-lying structure was relatively hydrophobic, probably corresponded with the region of its α-helix sides. Based on this finding, a micropatterned surface with the hydrophilic/hydrophobic regions was created using MHA and ODT, and zein was used as the secondary layers for growing NIH 3T3 cells. The cell culture revealed that cell growth was restricted to zein-absorbed MHA areas, whereas only very limited cell growth was observed in the zein-absorbed ODT areas (Wang et al., 2008a). This finding agrees with the conclusion of another report that the hydrophilic surface is favorable to fibroblast attachment and proliferation (Scotchford et al., 1998). The above studies indicate that zein can be used as a matrix material to adjust cellular spatial location via surface-sensitive molecule orientations."
    }, {
      "heading" : "2.3 Immunogenicity",
      "text" : "Immunogenicity is another key factor to be considered when a material is used in vivo, which is also closely related to the routes of administration and purpose of application (Michel et al., 2012). To date, only limited information is available concerning zein immunogenicity, and some contrary results have been reported. One of the earliest studies on zein immunogenicity reported that guinea pigs sensitized with zein via injection experienced anaphylaxis when receiving the second injection at intervals of 17 to 25 days (Wells, 1908). Subsequent study revealed that the daily ingestion of corn proteins could help guinea pigs to develop a systemic tolerance (Wells and Osborne, 1911). However, Johnson et al. reported that tolerance to α-zein did not occur in mice fed\nwith a maize-based diet (Johnson et al., 1990). Recently, a cooking- and digestion-resistant γ-zein of 50 kDa has been found to cause an IgE-mediated food allergy in sensitive individuals (Lee et al., 2005; Pasini et al., 2002). Similarly, another γ-zein of 27-kDa was reported to withstand pepsin digestion and to raise an immunogenic response in maize protein-allergic piglets and patients (Krishnan et al., 2011; Krishnan et al., 2010). The reported specific interaction of α-zein and IgA of patients with celiac disease suggested that zein or its digestion products may be presented by antigen-presenting cells to induce an immune response in these celiac patients (Cabrera-Chavez et al., 2012; Cabrera-Chavez et al., 2009). Interestingly, zein microparticles administered intramuscularly were found to elicit high antibody response (IgG) after boosting, whereas oral administration plus boosting caused low IgG response but an improved IgA level in intestine (Hurtado-Lopez and Murdan, 2006a). However, a recent patent reported that zein nanoparticles of 100-400 nm were non-immunogenic, whereas zein nanoparticles with a size larger than 400 nm elicited a significant immune response in mice after the third and fifth weeks of primary and booster immunization via subcutaneous injection (Perumal et al., 2009). Based on the above reports, it is still difficult to arrive at an indisputable conclusion about zein immunogenicity. Clearly, a comprehensive investigation is required to reveal the effects of various factors, such as form, size, protein dose, administration routes, on zein immunogenicity."
    }, {
      "heading" : "3. Carrier classes and morphologies",
      "text" : "Colloidal carrier systems are particulate or vesicular carriers with diameters ranging from nanometers to micrometers. In this section, we focus our attention on the classes and morphologies of the most frequently used zein-based colloidal carrier systems such as\nnano/microparticles and nano/microcapsules (Figure 2). In addition, other colloidal carrier systems (e.g., micelles and zein-stabilized Pickering emulsion) are introduced to provide a comprehensive view. Most of these systems can be easily fabricated and adjusted in size, surface charge, drug encapsulation and release. The reader desiring additional information on zein-based nano/microfibers is referred to recently published review (Zhang et al., 2015b)."
    }, {
      "heading" : "3.1 Nano/microparticles",
      "text" : "Zein-based nano/microparticles are a homogeneous matrix system that can be divided into pure and hybrid classes according to their compositions (Figure 2). Drug molecules could be physically dispersed or covalently conjugated to zein in particle matrices (Karthikeyan et al., 2012; Matsuda et al., 1989; Suzuki et al., 1989; Zou and Gu, 2013). Hydrophobic drugs show higher loading and encapsulation efficiency (EE) than hydrophilic drugs, which is closely related to the intrinsic hydrophobic property of zein molecules (Sousa et al., 2010; Suzuki et al., 1989). Because the zein isoelectric point is 6.2, pure zein particles usually show a strong aggregation tendency, especially in aqueous solutions with a neutral pH or in physiological pH (Patel et al., 2010a). To improve the colloid stability or to tailor the drug release profiles of zein particles, many researchers have attempted to produce hybrid particles by introducing other ingredients into the formulations (Hu et al., 2015; Muller et al., 2011; Sousa et al., 2010). Coating zein nanoparticle with other polymers is also reported to be an effective strategy to achieve mono-dispersion by tailoring the surface properties of particles (Luo et al., 2012; Luo et al., 2011; Luo et al., 2013b; Zhang et al., 2014; Zou and Gu, 2013). Besides, coating can result in an improved EE and a more sustained drug release (Davidov-Pardo et al., 2015b;\nZou and Gu, 2013). Some functionalized coating materials (e.g., sodium caseinate and d-α-tocopheryl polyethylene glycol 1000 succinate [TPGS]) are reported to enhance the membrane permeability of zein nanoparticles and thus the oral bioavailability of loaded drugs (Ahmed et al., 2015; Luo et al., 2013a; Zou and Gu, 2013). Phase separation, also known as coacervation or antisolvent precipitation, is the most frequently used method to fabricate pure or hybrid zein nano/microparticles (Liu et al., 2005; Wang and Padua, 2012) and is introduced in detail in the following section. In addition, chemical crosslinking (Matsuda et al., 1989), emulsification/solvent evaporation (Karthikeyan et al., 2012; Karthikeyan et al., 2014), spray drying (Chen and Zhong, 2014; de Sousa et al., 2012; Gomez-Estaca et al., 2012; Sousa et al., 2010), cold gelation (Chen et al., 2010; Chen and Subirade, 2009) and supercritical anti-solvent technologies (Zhong et al., 2008) are reported."
    }, {
      "heading" : "3.2 Nano/microcapsules",
      "text" : "Here, nano/microcapsules refer to a vesicular system with a distinct shell and a core-forming space that can entrap drugs (Xiao et al., 2011; Xu et al., 2015; Xu et al., 2011). Microcapsules also include a continuous matrix system composed of nanoparticles or have internal micro-voids (Zhong and Jin, 2009a; Zhong et al., 2009a). Bioactive agents can be distributed into the matrix through co-precipitation with zein or uploaded into the internal cavity by incubating the zein nanocapsules with the drug solution at high temperature (Xiao et al., 2011; Xu et al., 2015; Xu et al., 2011; Zhong and Jin, 2009a; Zhong et al., 2009a). The development of zein-based nano/microcapsules is usually undertaken to achieve the sustained release or controlled delivery of bioactive agents (Xiao et al., 2011; Xu et al., 2015; Xu et al., 2011; Zhong and Jin, 2009a; Zhong et al.,\n2009a). The diverse internal structures of the microcapsule matrix can be used to acquire the desired drug release profiles, which mainly depend on the formulation and fabrication method. Spray drying and supercritical anti-solvent technologies are the preferred methods to produce zein-based microcapsules (Xiao et al., 2011; Zhong and Jin, 2009a; Zhong et al., 2009a). The resultant capsules are reported to have a smooth surface and a spherical shape but usually with wrinkled morphologies due to the lack of a liquid core and fast solvent removal. Unlike microcapsules, zein nanocapsules are fabricated using a modified phase separation method. The resultant nanocapsules show a similar morphology to zein nanoparticles and have a size of less than 100 nm (Xu et al., 2015; Xu et al., 2011). Detailed information on the formation mechanism and fabrication process of zein nanocapsules is presented in section 4, Preparation methods."
    }, {
      "heading" : "3.3 Micelles",
      "text" : "Micelles belong to a type of specific colloidal system that can spontaneously form a spherical core-shell architecture by surfactant-like molecule self-assembly in appropriate solution. Both the core and the shell can be used to load drugs. Micelles can disassemble into free unimer molecules and release all loaded drugs upon dilution in the case that the unimer concentration is less than the critical micelle concentration (CMC). Although zein molecule contains amphiphilic domains (Wang et al., 2004; Wang et al., 2008a), zein itself cannot form micelles due to its lack of an intermediate dimension ratio of hydrophilic and hydrophobic segments. For this reason, conjugating a hydrophilic segment of PEG onto the zein molecule can produce a stable and biodegradable micelle system with zein as its hydrophobic core and PEG as its hydrophilic shell (Podaralla et al., 2012). The resultant micelles of 95-125 nm that give a low critical micelle concentration\nof 5.5 × 10 −2 g/L have been proved to be non-immunogenic. Further investigation revealed that the micelles could be used to solubilize the hydrophobic anticancer drug curcumin and to improve its aqueous solubility, stability and cellular uptake (Podaralla et al., 2012). The modifiability of both the protein core and the PEG shell offers these micelles great potential in biomedical applications. Besides, zein fragments degraded by alcalase are reported to show surfactant-like properties in terms of self-assembly and interfacial activity (Wang et al., 2015b). In addition, the resultant zein fragments displays a hydrolysis time-dependent CMC and can form spherical nanocomplexes with a hydrophobic drug via strong hydrophobic interactions in aqueous solution (Wang et al., 2015b)."
    }, {
      "heading" : "3.4 Zein-stabilized Pickering emulsions",
      "text" : "Pickering emulsion refers to a solid colloidal particle-stabilized emulsion without conventional surfactants (Aveyard et al., 2003; Chevalier and Bolzinger, 2013), and it usually displays a core-shell structure with large size, as shown in Figure 2. The shell is not an integrated matrix but a densely packed monolayer consisting of fine solid nanoparticles. The specific architecture is very promising for multi-drug delivery, as both the core and shell can be used as drug reservoirs (Wang et al., 2015a). These exterior particles should be insoluble but can be partly dispersed in both oil and water. With their suitable particle size and equilibrium contact angle, they can form a closed and packed monolayer surrounding a dispersed phase (Binks, 2002). Due to the high energy barrier required to remove the particles absorbed at the oil/water interface and the steric hindrance resulted from packed particle monolayer, the resultant shell structure endows the emulsion with great colloidal stability (Deshmukh et al., 2015). Pure zein particles of\nless than 100 nm prepared by phase separation technique has been reported to be an efficient stabilizer of oil in water Pickering emulsion (soy bean oil as the dispersed phase), resulting in a droplet size of 10-200 µm (de Folter et al., 2012). However, due to the intrinsic aggregation tendency of zein nanoparticles, this emulsion displayed a limited stability especially when the aqueous continuous phase had a low pH or high ionic strength (de Folter et al., 2012). This problem can be overcome through tuning the wettability of zein particles by introducing other ingredients, such as sodium stearate, chitosan and tannic acid (Gao et al., 2014; Wang et al., 2015a; Zou et al., 2015). Some of these ingredients can induce conformational changes of zein molecules to varying extents and confer the particles with higher adaptability (probably more appropriate particle size and contact angle) at the oil-water interface, thus leading to a greater emulsion stability (Gao et al., 2014; Zou et al., 2015). The use of zein-based Pickering emulsion is now mainly focused on the functional food industry. Further investigation is needed to illustrate its potential in biomedical applications such as oral drug delivery. The Pickering emulsion is usually prepared via a conventional shear-induced emulsification technique that is not presented here."
    }, {
      "heading" : "4. Preparation methods",
      "text" : "Various methods have been reported to produce zein-based nano/micro-carrier systems that vary in their physicochemical properties and thus in their applications. In this section, we put emphasis on both the preparation methods of zein-based particles/capsules and their advantages and limits. The fabrication methods include chemical crosslinking, emulsification/solvent evaporation and emulsification/precipitation/gelation techniques. Moreover, spray drying, supercritical anti-solvent technique and phase separation are\ndrawing more attention from researchers due to their simplicity and scale-up potential. These methods generally involve multiple steps and different mechanisms, which are closely related to the physicochemical properties of zein and its structure. Figure 3 summarizes the size ranges of zein-based particles/capsules that each method can produce and presents the corresponding precipitation/self-assembly mechanisms of zein molecules."
    }, {
      "heading" : "4.1 Chemical crosslinking",
      "text" : "The first report using chemical crosslinking to prepare zein microparticles was published by Matsuda et al. in 1989 (Matsuda et al., 1989; Suzuki et al., 1989). The authors declared that the encapsulation process was based on the glutaraldehyde-mediated intermolecular crosslinking reaction between zein and various anticancer drugs, such as polysaccharide-K, mitomycin, daunomycin or peplomycin. However, the crosslinking reaction may also occur between zein molecules because glutaraldehyde is an aggressive and indiscriminant crosslinking reagent that can easily react with phenol, imidazole, hydroxyl and amine groups in proteins (Habeeb and Hiramoto, 1968; Migneault et al., 2004). Due to the distinct hydrophobicity of zein and the increasing molecular weight, the intermolecular crosslinking reaction endows zein with a higher aggregation tendency and thus facilitates molecular self-assembly into microparticles upon exposure to aqueous solution. The fabrication method is illustrated in Figure 4. Briefly, the drug is dissolved in dimethyl sulfoxide (DMSO), a small volume of aqueous glutaraldehyde is added and mixed by stirring, and zein with/without catalysts is then added. After the crosslinking reaction occurs, the mixture is highly diluted with PVP aqueous solution followed by centrifugation, ultrasonication and lyophilization. The water volume must be kept to less\nthan 5% (v/v) in DMSO after adding the aqueous glutaraldehyde because the presence of large amounts of water will lead to the aggregation and precipitation of zein and thus undermine the crosslinking efficiency. The EE of drugs in microparticles is determined by drug/zein ratio and drug hydrophobicity. Hydrophobic drugs usually have a higher loading efficiency than hydrophilic drugs (Suzuki et al., 1989). However, adding a nucleophilic catalyst such as N, N-dimethylaminopyridine can lead to an improved EE for hydrophilic drugs. The resultant microparticles tend to aggregate into large particles after lyophilization and usually display slow and incomplete drug release due to delayed penetration of medium and crosslinked zein matrix. Considering the possible negative effect of crosslinking on the activity of drugs, chemical crosslinking may be more suitable for drugs without reactive groups or those that can recover their activity in vivo via hydrolysis or the breaking of covalent bonds formed by crosslinking. In addition, chemical crosslinking involves the use of toxic solvents and may bring potential toxicity risk during product development and evaluation. Thus, alternative crosslinkers and novel crosslinking techniques are necessary to ensure the safety of the procedure and final products."
    }, {
      "heading" : "4.2 Emulsification/solvent evaporation",
      "text" : "Emulsification/solvent evaporation refers to emulsifying an aqueous alcohol solution of drug/zein into an immiscible surfactant-containing oil (e.g., sesame oil) to acquire a water-in-oil emulsion as a template for carrier assembly (Karthikeyan et al., 2012; Karthikeyan et al., 2014). The internal phase of emulsion can solidify into rigid microparticles via solvent evaporation. Crosslinking agents (e.g., glutaraldehyde) can be added before solvent evaporation to obtain crosslinked microparticles (Figure 5).\nParticles collection usually needs filtration and the residual oil can be washed out with appropriate solvent. This method has been used to fabricate aceclofenac-loaded zein microparticles in sizes ranging between 30 and 300 μm for oral delivery (Karthikeyan et al., 2012). The crosslinking treatment was found to reduce the mean diameter of zein microparticles and to retard drug release but had no effect on the particle surface morphology and drug loading (Karthikeyan et al., 2012). Drug encapsulation efficiency can be improved by increasing the zein concentrations. In addition, some researchers declared that residual glutaraldehyde and thus possible side effects could be avoided (as evidenced by cytotoxicity assay) by using glutaraldehyde-saturated toluene as the crosslinking medium (Karthikeyan et al., 2012). This method can be used to encapsulate hydrophobic, amphiphilic and hydrophilic drugs (Karthikeyan et al., 2014). However, the sustained release ability of the microparticles follows a certain order of hydrophobic > hydrophilic > amphiphilic, which is closely related to the binding affinity of the drugs with zein (Karthikeyan et al., 2014)."
    }, {
      "heading" : "4.3 Emulsification/precipitation and emulsification/precipitation/gelation",
      "text" : "Emulsification/precipitation involves emulsifying aqueous solutions containing drug and zein into a surfactant-loaded oil to acquire a water-in-oil emulsion, with the water phase serving as a template for carrier preparation. Because zein is insoluble in neutral solution and no alcohol is contained in this system, the internal aqueous solution needs to be kept alkaline in the initial emulsion preparation process. After that, an acid soluble in oil (e.g., glacial acetic acid) is introduced and partitions into droplet to adjust its pH to near neutral (6.0). During this process, zein will precipitate and aggregate into particles with varied sizes (Chen and Subirade, 2009). The emulsification/precipitation/gelation technique is\nessentially a combination of emulsification/precipitation and emulsification/internal gelation, which can be used to fabricate hybrid zein microparticles (Chen et al., 2010; Chen and Subirade, 2009). The mechanism of internal gelation is based on oil-soluble acid-initiated calcium ion release and calcium ion-mediated polymer crosslinking (Poncelet et al., 1992; Poncelet et al., 1995). For this reason, calcium salt and another polymer (e.g., alginate or heat-denatured soy protein isolate [SPI]) that can be crosslinked by calcium ions must be incorporated into the formulation. Figure 6 depicts the preparation process of denatured SPI/zein microparticles via the emulsification/precipitation/gelation method. Here, glacial acetic acid has two roles: one is to neutralize the pH of the droplet phase to precipitate the zein molecules, and the other is to release calcium ions to initiate polymer gelation (Chen et al., 2010; Chen and Subirade, 2009). Zein precipitation and calcium ion release usually happen at the same time, and thus phase separation will not occur in the hybrid zein microparticles. The use of a large volume of calcium chloride solution allows the microparticles to partition into aqueous solution and thus further promote particle gelation and solidification. Compared with chemical crosslinking and emulsification/solvent evaporation, this method does not use toxic solvents or crosslinkers, and therefore avoids the potential toxicity of reagents and other undesirable side effects. In addition, it has a promising scale-up potential and may be used to encapsulate both hydrophobic and hydrophilic agents. The drug release profile can be tailored by tuning SPI/zein ratio (Chen and Subirade, 2009)."
    }, {
      "heading" : "4.4 Spray drying",
      "text" : "Spray-drying is a scalable technique that can fabricate various polymeric particles in a nanometer to sub-micrometer size range via commercially available spray dryers. The\nspray-drying procedure generally involves a) atomization of the feed liquid, b) solvent evaporation and particle formation and c) particle collection (Figure 7). The driving force assisting in atomization of the zein-contained feed liquid includes compressed air (Chen and Zhong, 2014; de Sousa et al., 2012; Sousa et al., 2010; Xiao et al., 2011; Zhong and Jin, 2009a) and an electrohydrodynamic force (the related method is also called electrospraying) (Gomez-Estaca et al., 2012). After atomization, as the solvent continuously evaporates from the atomized droplets, the material and drug gradually lose their solubility, form nuclei and finally grow into solid particles. The particle size can be adjusted by the original solute concentration in feed liquid and the droplet size of the atomized liquid (Vehring, 2008). The size of the droplet is further influenced by atomizer type and the physicochemical properties of the feed liquid (Wang et al., 2008b). In addition, solvent evaporation rate and solute diffusion coefficient during drying can significantly affect the morphology of the resulting particles (Vehring, 2008). As for detailed information and related equations proposed to estimate how the above factors influence particle size and morphology, the reader is referred to the published works (Nandiyanto and Okuyama, 2011; Vehring, 2008; Walters et al., 2014; Wang et al., 2008b). To date, using spray-drying to fabricate zein-based particles is mainly limited to hybrid microparticles and microcapsules (e.g., PLGA/zein systems) to obtain desired carrier microstructure and therefore the tailored drug release profiles (de Sousa et al., 2012; Sousa et al., 2010; Xiao et al., 2011; Zhong and Jin, 2009a). Zein is usually used as a hydrophobic polymer in the formulation to help the carrier achieve sustained release of the bioactive agents. The existing state of zein in feed liquid for spray drying is\nsolvent-dependent and involves two types: molecular dispersion and aggregate particle. The former requires an aqueous alcohol solution as the solvent and can be used to fabricate microcapsules (Xiao et al., 2011; Zhong and Jin, 2009a), whereas the latter uses dichloromethane as the dispersion solvent, and the resulting spray-dried products are generally microparticles (de Sousa et al., 2012; Sousa et al., 2010). The relationship between the existing states of zein and the morphologies of the resulting carriers involves the differential mass and heat transfer of the droplet during the spray-drying process (Vehring, 2008). Hydrophobic drugs usually have higher encapsulation efficiency and slower release profile than hydrophilic drugs, which strongly correlates to the molecular affinity of the drugs with zein as evidenced by NMR analyses (Sousa et al., 2012; Sousa et al., 2010). Besides micro-sized carriers, zein-based nanoparticles can also be produced by spray drying liquid containing already-formed zein nanoparticles (Chen and Zhong, 2014) or by the electrospraying of an aqueous alcohol solution of zein (Gomez-Estaca et al., 2012). In the latter case, the carrier size and morphology can be tailored from nano-sized spherical particles to micro-sized shrunk particles by adjusting key process parameters (e.g., zein concentration, feed flow rate and voltage) (Figure 7) (Gomez-Estaca et al., 2012)."
    }, {
      "heading" : "4.5 Supercritical anti-solvent technique",
      "text" : "Similar to spray drying, the supercritical anti-solvent technique (SAS) can also be used to fabricate micro/nano-sized particles and capsules (Zhong et al., 2009a; Zhong et al., 2008). The difference in these two drying techniques mainly concerns the process of solvent removal. Spray drying usually removes solvent using a warm air stream, whereas SAS mainly involves an aerosol solvent extraction process mediated by supercritical CO2.\nSAS required dissolving zein and drug in a CO2-miscible solvent system, which usually consists of water and alcohols (Zhong et al., 2009a; Zhong et al., 2008). Then, the resulting zein/drug solution is sprayed into supercritical CO2. With the continuous extraction of co-solvent from the atomized droplets, the zein and drug gradually lose their solubility, form nuclei and grow into solid microparticles. The whole process is analogous to spray drying, but the lower temperature and oxygen-free environment offer more advantages especially for heat- or oxidatively unstable drugs. The successful production of zein microparticles requires the proper combination of various processing factors (e.g., CO2 flow rate, zein concentration, alcohol and water/alcohol ratio) (Zhong et al., 2008). Generally, particle size can be tuned from micrometer to nanometer through adjusting the polarity of alcohol and the water/alcohol ratio. Decreased polarity and reduced water content can improve the extraction efficiency of the co-solvent, accelerate zein solidification and thus form smaller particles with narrower distribution (Zhong et al., 2008)."
    }, {
      "heading" : "4.6 Phase separation",
      "text" : "Phase separation, also known as liquid-liquid dispersion, coacervation or anti-solvent precipitation, has been widely used to fabricate zein-based nano/microparticles. Figure 8 depicts the process of phase separation to prepare zein-based micro/nanoparticles. Briefly, zein and drug need to be dissolved in an aqueous alcohol solution. Then, the solution is mixed with bulk deionized water as a non-solvent under continuous stirring followed by alcohol evaporation. The three-phase composition of zein, alcohol and water after mixing should be kept in the precipitation area or coacervation area of ternary phase diagram (for zein/ethanol/water system, see Figure 9-A). During the mixing process, clustering and\nnucleation may occur due to the supersaturation of zein induced by the decreasing alcohol concentration (Francois and Katz, 2005). Meanwhile, due to the high relative volatility of alcohol, stirring facilitates alcohol evaporation and thus leads to lower alcohol concentrations. As a result, the zein nucleation process is accelerated. The resulting nuclei can further grow by capturing non-aggregated solute molecules or by diffusion controlled Ostwald ripening, a thermodynamically-driven spontaneous process in which small particles dissolve and redeposit onto larger particles (Aubry et al., 2009; Kahlweit, 1975). However, in the case of a high zein concentration and thus a large number of nuclei, the growth of the nuclei is expected to occur mainly through random collisions of existing particles (Aubry et al., 2009). In addition, nucleation and nucleus growth may be influenced by interfacial turbulence occurring during mixing (Sternling and Scriven, 1959). Finally, particle aggregates reach a thermodynamically stable state with their final size attained through the adsorption of potential ions or surfactants. Furthermore, particle growth will also cease when the zein concentration in the solvent is below the solubility limit and Ostwald ripening is very limited. This particle formation process can be highly modified to produce various carriers. For example, introducing other ingredients into the non-solvent can fabricate core-shell particles (Luo et al., 2013b; Zhang et al., 2014), whereas using pre-formed sodium carbonate crystals to replace zein nuclei can produce hollow zein nanoparticles (namely nanocapsules) (Xu et al., 2015; Xu et al., 2011). In this latter case, sodium carbonate concentrations and zein/sodium carbonate weight ratios can be used to tailor the volume of the internal cavity and the shell thickness of the hollow zein particles. A high concentration of sodium carbonate leads to larger crystal sizes due to collision-mediated crystal growth and thus larger\ncavity size of the hollow zein nanoparticles. Contrastingly, a high ratio of zein to sodium carbonate results in more absorption and thus a thicker shell accompanied by a larger size (Xu et al., 2011). Another interesting study investigated solvent evaporation-induced conformation transition and self-assembly of zein molecules. It revealed that with alcohol evaporation, zein molecules experience a α-helix-to-β-sheet conformational transition due to the increasing solvent hydrophilicity, which is followed by molecular packing via hydrophobic interaction; the self-assembly further spreads into long ribbons, and finally, spherical aggregates form through ribbon curling and stacking (Wang and Padua, 2012). During zein self-assembly, the drug is expected to be encapsulated into the zein aggregates via hydrophobic interaction. To some extents, this may explain why hydrophobic drugs usually have a higher EE than hydrophilic drugs. Any factors affecting the above processes, such as zein desolvation, nucleation and nuclei growth, will influence the resultant particle characteristics and thus the drug loading and release profiles (Figure 8). For example, either ethanol, methanol or isopropanol can be used to fabricate zein nanoparticles (Muthuselvi and Dhathathreyan, 2006; Patel et al., 2010b; Zhong et al., 2009b). However, the order of resultant nanoparticle size is ethanol > isopropanol > methanol, probably due to the different alcohol evaporation rates and the differential solubility of zein and thus the distinct nucleation and nuclei growth rates (Patel et al., 2010b). In another study, gitoxin-loaded microparticles prepared from methanol and iso-propanol showed faster release kinetics than those of ethanol (Muthuselvi and Dhathathreyan, 2006). In addition to alcohol type, an improved shear rate, an increased initial alcohol concentration or a reduced zein concentration also resulted in smaller nanoparticles, which can be explained on the basis of dispersed\ndroplets breakup, zein nucleation and collision-induced nucleus growth (Podaralla and Perumal, 2012; Zhong and Jin, 2009b). Apart from the above factors, the dilution ratio and mixing method can also exert significant influence on the resulting particle characteristics. Different dilution ratios, that is, different alcohol/water ratios at the mixing stage, will determine the zein supersaturation concentration and thus the number of nuclei (Figure 9-A). Based on classic nucleation theory, high supersaturation produces massive nuclei, whereas low supersaturation leads to few stable nuclei (Horn and Rieger, 2001). Fewer nuclei with a high concentration of dissolved zein will produce larger particles at the final state via diffusion-controlled nucleus growth. Our previous study proved that zein particle size can be adjusted through tuning the addition rate of bulk water into zein-containing aqueous alcohol solution. A faster addition rate usually resulted in smaller particles under the same experimental condition. This result could be reasonably explained by the nucleation rate and nucleus growth model. At the beginning, the addition of water reduces both zein and ethanol concentrations. However, zein still remains in a molecular dispersion state, and the whole system is homogeneous under continuous stirring conditions. With the further addition of water, the critical supersaturation concentration of zein is reached and zein nucleation occurs. The rapid addition of water leads to one brief outburst of nuclei and a high nucleus concentration. The resulting nuclei will grow evenly by capturing dissolved zein molecules the rest of the time. As a result, small particles with low polydispersity index formed. In the case of the slow addition of water, zein nucleation will last for a while, and dissolved zein will be consumed competitively by nucleation and nuclear growth. The rest of the time, large particles may further grow via Ostwald ripening accompanied by a wide size distribution.\nTherefore, to obtain monodispersed zein nanoparticles, rapid mixing and thus a rapid nucleation rate should be satisfied during the particle fabrication process. The possible concentration changing of zein during particle formation are shown in Figures 9-B and C (LaMer and Dinegar, 1950). Besides the above factors, pH, temperature, viscosity of the system and other ingredients can also influence the particle properties by interfering with zein desolvation, nucleation and nucleus growth (Podaralla and Perumal, 2010). Maintaining the pH of the aqueous phase slightly above zein isoelectric point is reported to lead to a smaller particle size (Podaralla and Perumal, 2010). Introducing other ingredients into the formulation can produce core-shell particles and result in improved colloidal stability and controlled drug release, which is discussed in detail in the following section."
    }, {
      "heading" : "5. Challenges and solutions",
      "text" : "Colloidal stability and redispersibility after centrifugation and lyophilization appear to be two problems that may limit the applications of zein-based colloidal carrier systems in both food industry and pharmaceutical fields. The aggregation tendency of zein colloidal systems at near neutral pH or high ionic strength is because of diminished electrostatic repulsion and increased hydrophobic interactions (Rishi and Munir, 2001). In this section, the strategies that could solve these problems, and the underlying mechanisms are summarized and discussed."
    }, {
      "heading" : "5.1 pH adjustment",
      "text" : "Centrifugation and redispersion are usually necessary to remove residual alcohol and unencapsulated compounds during carrier preparation. However, high centrifugal force and long centrifugation time may lead to particle aggregation and therefore\nredispersibility problem. As a result, the yield of stable particles usually remains low after centrifugation. However, the problem can be solved by adjusting the pH of the dispersed solvent. The isoelectric point of zein is at pH 6.2. Employing a dispersed solvent for zein at 4-5 can effectively reduce centrifugation-mediated aggregation. The underlying mechanism is the protonation of zein and the resulting strong charge repulsion between particles. Under this condition, nanoparticles can be easily redispersed even after a long-term and high-speed centrifugation process. This strategy is also suitable to the coated zein nanoparticles by adjusting solvent pH away from the isoelectric point of coating material. In addition, keeping pH away from isoelectric point of zein or the coating materials is also beneficial to the long-term stability of the particles over storage. However, when the above carrier systems are redispersed in solutions with a pH near the isoelectric points of zein or coating materials, aggregation and coagulation may occur rapidly due to the diminished charge repulsion. This is especially true for pure zein nanoparticles at near neutral or physiological pH."
    }, {
      "heading" : "5.2 Stabilizers",
      "text" : "To further improve the colloidal stability and redispersibility of zein-based carrier systems, a series of stabilizers can be introduced into the formulations. These stabilizers include lecithin/poloxamer 188 (Podaralla and Perumal, 2010, 2012), sodium caseinate (Li et al., 2013; Patel et al., 2010a; Patel et al., 2010b), β-lactoglobulin (Chen et al., 2014), pectin (Hu et al., 2015) and lysine (Penalva et al., 2015). The principle of using these stabilizers is that they can absorb onto the surface of the nanoparticles via hydrophobic or electrostatic interactions, forming an isolation layer between zein matrix and solvent. Improved colloidal stability and redispersibility of zein particles mainly result from\nimproved colloidal interface properties such as electrostatic repulsion, steric exclusion or both (Patel et al., 2010a). Usually, steric exclusion is more advantageous than electrostatic repulsion. As presented above, electrostatic repulsion can be diminished near the isoelectric points of the coating materials, whereas steric exclusion effect is not notably affected by the change of environmental conditions. Based on this theory, McClements et al. developed a series of caseinate-dextran conjugates (Davidov-Pardo et al., 2015a; Davidov-Pardo et al., 2015c). The role of caseinate is to provide reactive amino groups for conjugation with dextran by Maillard reaction. On the other hand, it can endow the resultant conjugates with adsorption capacity onto the surface of zein nanoparticles. As expected, zein nanoparticles coated with the conjugates showed greater colloidal stability than those coated with only caseinate due to strong steric repulsions resulting from hydrophilic polysaccharide chains of dextran. Moreover, the colloidal stability of the coated zein nanoparticles could be further improved by increasing steric repulsions through increasing dextran molecular weight. The coated zein nanoparticles were extremely pH and temperature-resistent. They were stable at pH from 2.0 to 9.0, in the presence of CaCl2 up to 100 mM, and at temperature 30-90 °C for 30 min (Davidov-Pardo et al., 2015a). The significant improvement in colloidal stability of zein nanoparticles by the above strategies will widen their biomedical applications. It is worthy to note that besides improved colloidal stability, stabilizers may also influence other properties of carrier systems (e.g., EE, drug release profiles and cellular uptake). The representative studies using stabilizers to enhance physicochemical properties of zein-based carrier systems are summarized in Table 1. 5.3 Buffering agents and lyoprotectants\nFreeze-drying is usually necessary for both accurate evaluation of release profiles of nano/microparticles and long-term sample storage. However, zein-based carriers may aggregate during freeze-drying process due to hydrophobic interactions or the physical entanglement of polymer chains even in the presence of stabilizers (Wu et al., 2012). In some cases, zein particles may experience morphological changes during freeze-drying process (Zhong and Jin, 2009b). These problems can be solved to various extents by choosing suitable buffering agents and cry/lyoprotectants, such as mannitol and trehalose (Muthuselvi and Dhathathreyan, 2006; Penalva et al., 2015; Podaralla and Perumal, 2010, 2012). Lyoprotectant mannitol is known to have the ability to form supporting structure for particles by crystallization during the slow drying process, whereas trehalose can replace water molecules around particles and to remain their spatial structure via bulk hydrogen bond interactions (Jain and Roy, 2009). Citrate and phosphate buffers are common buffering agents. However, citrate buffer was found to be more effective in preventing particles from aggregation than phosphate buffer due to citric acid-mediated amino group crosslinking and resistance to pH change during lyophilization (Podaralla and Perumal, 2012). For zein nanoparticle formulations requiring lyophilization, more studies are still needed to remove the above issues and illustrate the related mechanisms. Of note, when a zein particle-based solid form such as tablet is preferable (Gong et al., 2011; Liu et al., 2005), the above stabilization strategies may be avoided as no colloidal stability and redispersibility required in that system unless other functions are needed."
    }, {
      "heading" : "6. Biomedical applications",
      "text" : "The potential applications of zein-based nano/micro-carrier systems have been widely investigated by researchers from food and pharmaceutical industries. The benefits of zein-based nano/micro-carrier systems can be divided into four categories: a) controlled release, b) improved stability of bioactive agents, c) controlled delivery and d) enhanced cellular uptake and oral bioavailability of bioactive agents. In addition, conventional dosage forms (e.g., tablets and inserts) made from zein microparticles are also introduced here to illustrate their potential as the foundation for future medical practices (de Sousa et al., 2012; Gong et al., 2011; Liu et al., 2005). Zein nano/microparticle-based films and their biomedical applications (e.g., medical device coatings) have been reviewed in a previous article (Zhang et al., 2015a) and are not restated here."
    }, {
      "heading" : "6.1 Controlled release of bioactive agents",
      "text" : "Controlled release of bioactive agents is usually preferable to achieve desired therapeutic effects in both enteral and parenteral administrations. Zein-based nano/micro-carriers as a sustained or controlled-release drug delivery system are based on several advantages of zein polymer: a) zein is hydrophobic; b) zein can be further crosslinked; c) zein can withstand gastric pH; d) zein colloidal systems are more robust against digestion than zein (Lau et al., 2013). Various strategies that have been used to tailor drug release profiles are summarized and reviewed in this section. It should be noted that drug release profiles are the consequence of formulation and environmental factors (e.g., enzymes, pH and ionic strength). For instance, higher pH and higher ionic strength resulted in stronger molecular attraction between zein and its payload lysozyme and thus a slower release of\nlysozyme from zein microparticles (Zhong and Jin, 2009a; Zhong et al., 2009a). The similar influence of pH on drug release from zein matrices was also found in recent studies (Bouman et al., 2015). In another study, ovalbumin-loaded zein microparticles was reported to show a very limited release of ovalbumin in PBS at pH 7.4 due to the extreme resistance of microparticles to degradation (Hurtado-Lopez and Murdan, 2006b; Hurtando-Lopez and Murdan, 2005). However, adding pepsin or pancreatin enzyme significantly promoted the degradation of zein microparticles, suggesting that accelerated drug release may be achieved following oral administration (Hurtado-Lopez and Murdan, 2006b). The above studies suggested that environmental factors relating to routes of administration must be considered when attempting to achieve reliable drug release profiles and in-vitro in-vivo correlation."
    }, {
      "heading" : "6.1.1 Crosslinked microparticles",
      "text" : "Crosslinking can significantly influence drug release profiles through modifying carrier microstructures or conjugating drugs with the zein matrix. In the former case, sustained drug release is thought to result from both the hydrophobicity of zein and the retarded penetration of the medium into the crosslinked zein matrix. Thus, the release sustainability can be fine-tuned by changing the extent of crosslinking. In the latter case, zein erosion or the breaking of the covalent bonds between drug and zein is a precondition for an efficient drug release. For instance, glutaraldehyde-crosslinked zein microparticles developed by emulsification/solvent evaporation method displayed a crosslinking extent-dependent drug release profiles (Karthikeyan et al., 2012). The particles crosslinked with 0.25 ml of glutaraldehyde-saturated toluene showed an extended release of aceclofenac up to 24 h, whereas the drug release from uncrosslinked\nmicroparticles only sustained for 12 h in simulated gastrointestinal fluids. When microparticles crosslinked with 1.0 ml of glutaraldehyde-saturated toluene, an enhanced sustainability of up to 72 h was obtained due to the more compact microstructures (Figure 10) (Karthikeyan et al., 2012). In the case of crosslinking that occurred between zein and drugs, crosslinking strategy is a double-edged sword. On the one hand, both hydrophilic and hydrophobic drugs could be loaded into zein carriers and high EE and loading efficiency can be easily achieved. However, on the other hand, a slow and incomplete release may occur due to non-cleavable conjugation of drug with zein matrix (Matsuda et al., 1989; Suzuki et al., 1989). Besides, crosslinking might cause the activity loss of the drug. Thus, while keeping the above benefits of crosslinking in mind, one should pay attention to its potential negative influence on drug release and activity. A cleavable crosslinking or non-covalent crosslinking may be helpful to solve these problems."
    }, {
      "heading" : "6.1.2 Complex microparticles",
      "text" : "Desirable drug release profiles that are difficult to obtain based on a single component may be achieved through appropriate combination of them with zein. The mechanism underlying the controlled drug release is the tailorable microstructure and swelling behavior of the resultant mixture matrix and thus the controlled diffusion coefficient of drugs. For example, introducing hydrophilic SPI into zein matrix can decrease the hydrophobicity of the particle matrix and improve its hydration efficiency and finally result in a SPI concentration-dependent swelling behavior [71, 72]. Similar phenomena were also found in the combination of PLGA and zein (Sousa et al., 2010). The modulated swelling can be used to tailor drug release profiles through encapsulation of\ndrug into the complex microparticles. For instance, SPI/zein microparticle system was successfully used to achieve constant release of vitamin B2 in simulated gastrointestinal solutions, whereas zein microparticles and SPI microparticles displayed a very slow release and a burst release, respectively (Chen and Subirade, 2009). The SPI/zein microparticles can also help riboflavin to reach near zero-order absorption kinetics in fasting and prandial states in an enzyme-contained artificial digestive system (Chen et al., 2010). In the case of PLGA/zein combination, increasing zein content in the formulations eliminated the burst release phase and led to a delayed release of the drug (Sousa et al., 2010). The delayed drug release is mainly due to the less hydration efficiency and the more compact microstructure of the particles resulted from the faster aggregation of zein during fabrication (Sousa et al., 2010). Besides SPI and PLGA, other ingredients, such as thymol and glycerol, have been reported to have the capacity to adjust the drug release profiles of zein-based colloidal carriers (Zhong and Jin, 2009a). For instance, the addition of thymol led to a more homogeneous matrix and thus a more sustained release of lysozyme compared with zein microcapsules (Zhong and Jin, 2009a). The microstructure change was proposed to be due to the plasticizing effect of thymol during carrier formation."
    }, {
      "heading" : "6.1.3 Tableted microparticles",
      "text" : "Conventional dosage forms (e.g., tablet and insert) have great advantages over other liquid and semi-solid presentations, such as its ease of manufacturing, convenience in administration, accurate dosing and stability. Lyophilized or spray-dried zein microparticles loaded with drugs can be used as primary component to be formulated into tablets and inserts (de Sousa et al., 2012; Liu et al., 2005). The compression process\nrequired for the tablet and insert preparation will reduce the interface area of preparations available to the dissolution media, and therefore result in an extended drug release. Theoretically, drug release profiles can be tailored by adjusting zein microparticle formulation, compression parameters and introducing fillers into tablets and inserts. For instance, ivermectin in zein microparticle-based tablet form exhibited lower release rates in pH 7.4 PBS than that of microparticles alone due to the decreased interface area available to the dissolution media (Liu et al., 2005). However, the presence of pepsin significantly accelerated its release from the tablet and gave a zero-order release profile via zein degradation (Figure 11) (Liu et al., 2005). To further improve its feasibility of oral administration, various fillers were introduced into the formulation to shorten the disintegration time of the tablet. Eventually, less than 15 min disintegration time was reached by combining zein microparticles, calcium hydrophosphate, magnesium stearate and sodium carboxymethyl starch (Gong et al., 2011). The subsequent pharmacokinetics analysis using dogs revealed a longer plasma mean residence time of up to 55 h (Gong et al., 2011). The oral bioavailability of the zein microparticle-based tablet was 132.65% that of commercial ivermectin tablet Yilijia, and its efficiency for the treatment of demodicidosis in dogs was also confirmed. In another study, tetracycline-loaded PLGA/zein microparticles developed using a spray-drying technique were also compressed into round insert to treat periodontal disease (de Sousa et al., 2012). Effective tetracycline release at a level required for antimicrobial activity was achieved over 15 days, and no cytotoxic effect was observed (de Sousa et al., 2012). The above studies suggest that formulating zein microparticles into conventional solid dosage forms could be a promising strategy to tailor drug release and to enhance their bioavailability and therefore efficacy."
    }, {
      "heading" : "6.1.4 Coated nanoparticles",
      "text" : "Coating zein particles is also an effective strategy to achieve the controlled release of bioactive agents (Luo et al., 2012; Luo et al., 2011; Luo et al., 2013b). The coating materials mainly involve chitosan and carboxymethyl chitosan (CMCS) which are usually dissolved in aqueous phase for zein nanoparticle coating. It was proved that hydrogen bonds and electrostatic interactions between zein and chitosan or CMCS molecules are the major driving forces for coating layer formation (Luo et al., 2011). The release profile of loaded cargoes is zein concentration- and chitosan/zein ratio-dependent. Increasing zein concentrations and chitosan/zein ratios alleviated the burst release and decreased accumulative release of drugs in both PBS and simulated gastrointestinal tract conditions in the presence of enzymes. In addition, coating particles with chitosan and CMCS resulted in decreased particle size and improved EE. Crosslinking CMCS with calcium ions further improved EE by forming a thicker and denser coating around the zein nanoparticles (Luo et al., 2012). The thicker and denser coating resulted in a more controllable release of bioactive agents in both PBS and simulated gastrointestinal fluids (Luo et al., 2012; Luo et al., 2013b). Similarly, TPGS-coated zein nanoparticles also owned increased EE of daidzin and a slower release in both PBS (pH 7.4) and simulated digestive fluids (Zou and Gu, 2013). However, different from chitosan and CMCS, TPGS exhibited special interactions with zein. The lipophilic segment of the TPGS, α-tocopherol, partly penetrated in the metrics of the zein nanoparticle through hydrophobic interactions, whereas its hydrophilic polyethylene glycol chains protruded out from the particle surface and formed a hydrophilic shell. Theoretically, the length and the extent of branching of polyethylene glycol chains may be used to tailor drug release\nprofiles. More studies are required to illustrate their potential in controlled drug release.\nMore recently, pH-sensitive zein nanoparticles using metal-tannic acid (TA) films as coating materials were developed (Liang et al., 2015). The formation of metal-tannic acid film around particles is started by tannic acid adsorption and promoted by pH-dependent, multivalent coordination bonding. The resultant nanoparticles show not only an improved EE and a good cellular biocompatibility, but also pH-controlled drug release profiles (Figure 12). The mechanisms underlying the controlled release is low pH-mediated cleavage of metal-tannic acid coordination bonds and therefore the disassembly of metaltannic acid films (Zheng et al., 2011). Interestingly, drug release profiles can also be tailored by metal species via metal-ligand bond energy-dependent disassembly kinetics. Strong coordination bonding will diminish the pH responsibility of the coated zein nanoparticles (Liang et al., 2015)."
    }, {
      "heading" : "6.2 Improved stability",
      "text" : "Encapsulation is an effective strategy to protect bioactive agents from denaturing factors in the external environment. As mentioned above, zein is hydrophobic and has reduced susceptibility to proteolytic degradation and gastric juice. Therefore, zein-based colloidal carriers can be used as vehicles to protect drug from the harsh gastrointestinal conditions of pH and digestive enzymes during their oral delivery. This advantage has been confirmed by several reports. For example, encapsulating catalase or superoxide dismutase into zein nanoparticles was shown to protect them from enzyme-mediated degradation and keep 40-60% of the activities of intact therapeutic proteins at pH 7.0, whereas the activities of the free therapeutic proteins remained at 5-10% in pH 1.3 with pepsin (Lee et al., 2013). Similarly, zein nano/microparticles have also successfully\nprotected DNA (Regier et al., 2012), curcumin (Patel et al., 2010b), abamectin (Demchak and Dybas, 1997) and fish oil (Zhong et al., 2009b) from pH, enzymes, light and oxygen-mediated degradation via encapsulation. In addition, coating zein particles can further provide better protection of cargoes against harsh external conditions (Davidov-Pardo et al., 2015c; Luo et al., 2012; Luo et al., 2011; Luo et al., 2013b). Besides zein-based particles, micelle systems such as PEG-zein micelles and zein hydrolysate micelles were reported to improve the stability of curcumin via encapsulation and solubilization (Podaralla et al., 2012; Wang et al., 2015b)."
    }, {
      "heading" : "6.3 Targeted delivery",
      "text" : "Delivery of drugs to the desired site is usually required to reduce their toxicity and improve their therapeutic efficacy. Zein-based colloidal systems have been revealed as very promising carriers for achieving these purposes. For instance, aceclofenac-loaded zein microparticles crosslinked with glutaraldehyde were reported to significantly delay the release of the entrapped drug (14%) in pH 1.2 simulated gastric fluid during 2 h-incubation, whereas almost 79% of the drug was released at 72 h when incubated in simulated intestinal fluid (Karthikeyan et al., 2012). Aceclofenac is a water-insoluble nonsteroidal anti-inflammatory drug that generally induces gastric mucosal injury with long-term use. Thus, retarding early release of aceclofenac in the stomach is proposed to be able to reduce its side effect. In another study, 5-fluorouracil-loaded zein particles of less than 150 nm were found to exhibit a passive targeting to liver parenchymal cells with a relative uptake rate of 2.79 after intravenous injection in mice (Lai and Guo, 2011). The specific liver-targeting delivery is proposed to be due to successful escape of zein nanoparticles from reticuloendothelial system-mediated clearance. Similarly, hollow zein\nnanocapsules with the a size less than 100 nm also displayed a liver-targeting effect following intravenous injection in mice (Xu et al., 2015). In contrast, citric acid-crosslinked zein nanocapsules preferentially targeted the kidneys and showed a prolonged residence time (Figure 13) (Xu et al., 2015). The change of targeting sites is due to the improved resistance of crosslinked carriers against degradation and their insufficient elimination in kidneys. The above in vivo distribution properties of zein-based colloidal carrier systems revealed that zein-based nanocarriers could be potentially used as vehicle to target liver and kidney, two of the main organs of human, and treat related diseases. However, further study is required to clarify the detailed mechanisms and the possible effect of pathological conditions on their performance in animal models."
    }, {
      "heading" : "6.4 Improved cellular uptake and oral bioavailability",
      "text" : "To date, the evaluation of cellular uptake and bioavailability has mainly been limited to zein-based nanoparticle systems, especially those with a core/shell structure. The fact that few studies on pure zein nanoparticles exist is mainly due to the poor redispersibility and aggregation tendency of the particles in various media. As mentioned in section 5, some shell materials not only stabilize zein-based colloidal carriers but also endow them with improved permeation and absorption capacity. For instance, caseinate-coated zein nanoparticles showed enhanced cellular uptake in both caco-2 cells and HeLa cells (Dong et al., 2016; Luo et al., 2013a). The nanoparticles are delivered into HeLa cells mainly via macropinocytosis, whereas the particle uptake into caco-2 cells involved an energy-dependent endocytosis process that could be improved by increasing the sodium caseinate concentrations and extending the incubation time. Besides, caseinate-coated\nzein nanoparticles also showed good mucoadhesive property and improved permeation across caco-2 cell monolayers, which suggests that an improved oral bioavailability of bioactive agents may be achieved via extended retention time and high permeability (Luo et al., 2013a; Patel et al., 2010b). The advantages of caseinate-coated zein nanoparticles have been recently confirmed by an enhanced pharmacokinetic profile of simvastatin in rats, and resulted in a 3-fold higher oral bioavailability compared with simvastatin suspension (Ahmed et al., 2015). Similarly, due to the improved mucoadhesive property and tissue permeability, the oral bioavailability of atorvastatin and resveratrol was also improved by encapsulation into zein nanoparticles (Hashem et al., 2015; Penalva et al., 2015). Of them, atorvastatin-loaded zein nanoparticles showed 4-fold that of the commercially available tablets (Hashem et al., 2015).\nBesides, TPGS-coated zein nanoparticles were found more efficient in both cellular uptake and membrane permeation than pure drug, and daidzin with TPGS-coated zein nanoparticles showed a 1.4-fold higher oral bioavailability than the drug solution group in mice (Zou and Gu, 2013). The absorption-enhanced mechanism was due to effective particle transcytosis and TPGS-mediated P-glycoprotein inhibition and therefore less efflux of free drug released from nanoparticles into plasma. In addition to zein-based nanoparticles, PEG-zein micelles and tableted zein microparticles were reported to enhance the cellular uptake and oral bioavailability of encapsulated agents, respectively (Gong et al., 2011; Podaralla et al., 2012). However, more studies are required to clarify the related mechanisms and key factors which affect cellular uptake and oral delivery efficiency of the above carriers.\n7. Conclusions and perspectives\nThis review attempts to present an overall discussion of zein-based nano/micro-carrier systems in both fabrication and biomedical applications. Fundamental aspects of zein, such as its structure, biocompatibility and immunogenicity, have also been summarized and discussed. It is clear that zein can be formulated into various nano/micro-carrier systems to encapsulate and protect bioactive agents, tailor their release and delivery behaviors and improve their cellular uptake and bioavailability. As discussed, zein can be fabricated into nano/microparticles, nano/microcapsules, micelles and Pickering emulsion, all of which can be further functionalized through coating, crosslinking or conjugation. The resultant advanced carrier systems display improved properties in terms of stability, drug release and delivery efficiency. Some even display better performance (e.g., oral bioavailability) than the commercially available products (Ahmed et al., 2015; Gong et al., 2011; Hashem et al., 2015).\nNevertheless, translation of the above systems from lab bench to bedside requires more work to evaluate not only their reproducibility, biocompatibility and immunogenicity but also their scalability, storage stability and cost. To date, several studies have confirmed that both zein film and its degradation products have acceptable cytocompatibility with several types of cells. However, much work is still needed to reveal its biocompatibility in other forms and by other administration routes. Similarly, a comprehensive study is also required to clarify the effects of various factors, such as form, size, protein dose and administration routes, on zein immunogenicity. In addition, there is very limited information on the in vivo fate (e.g., uptake, distribution, degradation and elimination) of zein-based nano/micro-carrier systems containing bioactive agents especially under pathological conditions. Studies tackling these problems will help us to illustrate a) the\nsuitability of zein as a tissue engineering material; b) whether zein-based nano/micro-carrier systems are safe when used in parenteral routes of administration and c) what benefits can be achieved by using zein-based carrier systems. On the other hand, most of the fabrication techniques are still limited to lab scale, and some of them lack detailed investigations of various process parameters. For instance, even for the most used technique of phase separation, some factors (e.g., dilution ratio and mixing methods) influencing carrier formation and drug loading still remain unclear. Several techniques even involve using toxic organic solvents, and little is known about residual solvents and their effect on carrier performance. All of these issues may offer considerable challenges to future production due to the strickt regulatory requirements for biomedical products. Hence, much work remains to be done on both the optimization of the present techniques and the novel technology development for the large-scale production of zein-based nano/micro-carrier systems.\nLast but not least, although the key factors controlling carrier formation and therefore the drug release and delivery have been discussed in many works, there is still an urgent need to illustrate the fundamental mechanisms of carrier formation and the interactions of the resultant carriers with target cell and tissue. For example, what kind of conformational transformation of zein takes place during various carrier fabrication processes? How does the structurally changed zein self-assemble into carriers? How is the added bioactive agent encapsulated into carriers during zein self-assembly? How do additives interfere with zein self-assembly and carrier formation? How do the resultant carriers interact with target cell and tissue? Such knowledge will help us clarify the related mechanisms and key factors that influence carrier microstructures and drug encapsulation and thus the\nproperties of the resulting carriers. Without this knowledge, we can only follow trial-and-error procedure to optimize the formulation and process parameters of zein-based nano/micro-carrier systems. In this case, it will also be difficult to predict their release and delivery behaviors under both in vitro and in vivo conditions."
    }, {
      "heading" : "Acknowledgments",
      "text" : "This work was supported by the Fundamental Research Funds for the Central Universities (Grant No. 101832013), the Jilin Province Science and Technology Development Plan (Grant No. 20140309007YY) and Key Projects in the Twelfth Five-year Plan Period (Grant No. 2013ZX10004608-003)."
    } ],
    "references" : [ {
      "title" : "Optimization of caseinate-coated simvastatin-zein nanoparticles: improved bioavailability and modified release characteristics. Drug design, development and therapy",
      "author" : [ "O.A. Ahmed", "K.M. Hosny", "M.M. Al-Sawahli", "U.A. Fahmy" ],
      "venue" : "Anonymous,",
      "citeRegEx" : "Ahmed et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Ahmed et al\\.",
      "year" : 2015
    }, {
      "title" : "Nanoprecipitation of polymethylmethacrylate by solvent shifting: 1. Boundaries",
      "author" : [ "J. Aubry", "F. Ganachaud", "J.P. Cohen Addad", "B. Cabane" ],
      "venue" : "Adv. Colloid Interface Sci",
      "citeRegEx" : "Aubry et al\\.,? \\Q2009\\E",
      "shortCiteRegEx" : "Aubry et al\\.",
      "year" : 2009
    }, {
      "title" : "structure in solution by circular dichroism",
      "author" : [ "T.C. Bicudo", "L.A. Forato", "L.A. Batista", "L.A. Colnago" ],
      "venue" : "Current Opinion in Colloid & Interface Science",
      "citeRegEx" : "Bicudo et al\\.,? \\Q2005\\E",
      "shortCiteRegEx" : "Bicudo et al\\.",
      "year" : 2005
    }, {
      "title" : "Hydrophobicity and pH",
      "author" : [ "V. Cabra", "R. Arreguin", "R. Vazquez-Duhalt", "A. Farres" ],
      "venue" : "Pharmaceutical research 33,",
      "citeRegEx" : "Cabra et al\\.,? \\Q2006\\E",
      "shortCiteRegEx" : "Cabra et al\\.",
      "year" : 2006
    }, {
      "title" : "Bovine milk caseins and transglutaminase-treated cereal prolamins are differentially recognized by IgA of celiac disease patients according to their age",
      "author" : [ "F. Cabrera-Chavez", "O. Rouzaud-Sandez", "N. Sotelo-Cruz", "A.M. Calderon de la Barca" ],
      "venue" : "J Agric Food Chem",
      "citeRegEx" : "Cabrera.Chavez et al\\.,? \\Q2009\\E",
      "shortCiteRegEx" : "Cabrera.Chavez et al\\.",
      "year" : 2009
    }, {
      "title" : "Tangeretin-loaded protein nanoparticles fabricated from zein/beta-lactoglobulin: Preparation, characterization, and functional performance",
      "author" : [ "J.J. Chen", "J.K. Zheng", "D.J. McClements", "H. Xiao" ],
      "venue" : "Food Chem",
      "citeRegEx" : "Chen et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Chen et al\\.",
      "year" : 2014
    }, {
      "title" : "Emulsions stabilized with solid nanoparticles: Pickering emulsions",
      "author" : [ "Y. Chevalier", "M.A. Bolzinger" ],
      "venue" : "Biomacromolecules",
      "citeRegEx" : "Chevalier and Bolzinger,? \\Q2013\\E",
      "shortCiteRegEx" : "Chevalier and Bolzinger",
      "year" : 2013
    }, {
      "title" : "Recent advances in food-packing, pharmaceutical and biomedical applications of zein and zein-based materials. International journal of molecular sciences",
      "author" : [ "E. Corradini", "P.S. Curti", "A.B. Meniqueti", "A.F. Martins", "A.F. Rubira", "E.C. Muniz" ],
      "venue" : null,
      "citeRegEx" : "Corradini et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Corradini et al\\.",
      "year" : 2014
    }, {
      "title" : "Zein Nanoparticles Prepared by Liquid Antisolvent Coprecipitation",
      "author" : [ "G. Davidov-Pardo", "I.J. Joye", "D.J. McClements" ],
      "venue" : "J Agric Food Chem",
      "citeRegEx" : "Davidov.Pardo et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Davidov.Pardo et al\\.",
      "year" : 2015
    }, {
      "title" : "Oil-in-water Pickering emulsions stabilized by colloidal particles from the water-insoluble protein zein",
      "author" : [ "J.W.J. de Folter", "M.W.M. van Ruijven", "K.P. Velikov" ],
      "venue" : "Soft Matter 8,",
      "citeRegEx" : "Folter et al\\.,? \\Q2012\\E",
      "shortCiteRegEx" : "Folter et al\\.",
      "year" : 2012
    }, {
      "title" : "Photostability of Abamectin/Zein Microspheres. Journal of agricultural and food chemistry",
      "author" : [ "R.J. Demchak", "R.A. Dybas" ],
      "venue" : null,
      "citeRegEx" : "Demchak and Dybas,? \\Q1997\\E",
      "shortCiteRegEx" : "Demchak and Dybas",
      "year" : 1997
    }, {
      "title" : "nanoparticle and its anti-cancer effect: Preparation, in vitro evaluation, and cellular uptake",
      "author" : [ "Q. Sun", "J.Y. Wang" ],
      "venue" : "Colloids Surf B Biointerfaces",
      "citeRegEx" : "J. et al\\.,? \\Q2004\\E",
      "shortCiteRegEx" : "J. et al\\.",
      "year" : 2004
    }, {
      "title" : "Potential peptide carriers: amphipathic proline-rich peptides derived from the N-terminal domain of gamma-zein",
      "author" : [ "J. Fernandez-Carneado", "M.J. Kogan", "S. Castel", "E. Giralt" ],
      "venue" : "Angewandte Chemie",
      "citeRegEx" : "Fernandez.Carneado et al\\.,? \\Q2004\\E",
      "shortCiteRegEx" : "Fernandez.Carneado et al\\.",
      "year" : 2004
    }, {
      "title" : "Conformation of the Z19 prolamin by FTIR, NMR, and SAXS",
      "author" : [ "L.A. Forato", "A.C. Doriguetto", "H. Fischer", "Y.P. Mascarenhas", "A.F. Craievich", "L.A. Colnago" ],
      "venue" : "J Agric Food Chem",
      "citeRegEx" : "Forato et al\\.,? \\Q2004\\E",
      "shortCiteRegEx" : "Forato et al\\.",
      "year" : 2004
    }, {
      "title" : "Protein-based pickering emulsion and oil gel prepared by complexes of zein colloidal particles and stearate",
      "author" : [ "Z.M. Gao", "X.Q. Yang", "N.N. Wu", "L.J. Wang", "J.M. Wang", "J. Guo", "S.W. Yin" ],
      "venue" : "J Agric Food Chem",
      "citeRegEx" : "Gao et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Gao et al\\.",
      "year" : 2014
    }, {
      "title" : "Tablets based on compressed zein microspheres for sustained oral administration: design, pharmacokinetics, and clinical study",
      "author" : [ "S.J. Gong", "S.X. Sun", "Q.S. Sun", "J.Y. Wang", "X.M. Liu", "G.Y. Liu" ],
      "venue" : "J Biomater Appl 26,",
      "citeRegEx" : "Gong et al\\.,? \\Q2011\\E",
      "shortCiteRegEx" : "Gong et al\\.",
      "year" : 2011
    }, {
      "title" : "atorvastatin. International journal of nanomedicine",
      "author" : [ "D. Horn", "J. Rieger" ],
      "venue" : "Angewandte Chemie",
      "citeRegEx" : "Horn and Rieger,? \\Q2001\\E",
      "shortCiteRegEx" : "Horn and Rieger",
      "year" : 2001
    }, {
      "title" : "An investigation into the adjuvanticity and immunogenicity of zein microspheres being researched as drug and vaccine carriers",
      "author" : [ "P. Hurtado-Lopez", "S. Murdan" ],
      "venue" : "J Pharm Pharmacol",
      "citeRegEx" : "Hurtado.Lopez and Murdan,? \\Q2006\\E",
      "shortCiteRegEx" : "Hurtado.Lopez and Murdan",
      "year" : 2006
    }, {
      "title" : "Effect of trehalose on protein structure. Protein science : a publication of the Protein Society",
      "author" : [ "N.K. Jain", "I. Roy" ],
      "venue" : "Sci. Technol",
      "citeRegEx" : "Jain and Roy,? \\Q2009\\E",
      "shortCiteRegEx" : "Jain and Roy",
      "year" : 2009
    }, {
      "title" : "Ostwald ripening of precipitates. Advances in colloid and interface science",
      "author" : [ "M. Kahlweit" ],
      "venue" : "Industrial Crops and Products",
      "citeRegEx" : "Kahlweit,? \\Q1975\\E",
      "shortCiteRegEx" : "Kahlweit",
      "year" : 1975
    }, {
      "title" : "Selective interactions of zein microspheres with different class of drugs: an in vitro and in silico analysis",
      "author" : [ "K. Karthikeyan", "E. Vijayalakshmi", "P.S. Korrapati" ],
      "venue" : "AAPS PharmSciTech 15,",
      "citeRegEx" : "Karthikeyan et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Karthikeyan et al\\.",
      "year" : 2014
    }, {
      "title" : "Maize 27 kDa gamma-zein is a potential allergen for early weaned pigs",
      "author" : [ "H.B. Krishnan", "M.S. Kerley", "G.L. Allee", "S. Jang", "W.S. Kim", "C.J. Fu" ],
      "venue" : "J Agric Food Chem",
      "citeRegEx" : "Krishnan et al\\.,? \\Q2010\\E",
      "shortCiteRegEx" : "Krishnan et al\\.",
      "year" : 2010
    }, {
      "title" : "Encapsulation of hydrocortisone and mesalazine in zein microparticles",
      "author" : [ "E.T. Lau", "S.J. Giddings", "S.G. Mohammed", "P. Dubois", "S.K. Johnson", "R.A. Stanley", "P.J. Halley", "K.J. Steadman" ],
      "venue" : "Pharmaceutics",
      "citeRegEx" : "Lau et al\\.,? \\Q2013\\E",
      "shortCiteRegEx" : "Lau et al\\.",
      "year" : 2013
    }, {
      "title" : "Preparation of water-soluble antimicrobial zein nanoparticles by a modified antisolvent approach and their characterization",
      "author" : [ "K.K. 388-393. Li", "S.W. Yin", "Y.C. Yin", "C.H. Tang", "X.Q. Yang", "S.H. Wen" ],
      "venue" : "J Food Eng",
      "citeRegEx" : "Li et al\\.,? \\Q2013\\E",
      "shortCiteRegEx" : "Li et al\\.",
      "year" : 2013
    }, {
      "title" : "Supramolecular design of coordination bonding architecture on zein nanoparticles for pH-responsive anticancer drug delivery",
      "author" : [ "H. Liang", "B. Zhou", "J. Li", "W. Xu", "S. Liu", "Y. Li", "Y. Chen", "B. Li" ],
      "venue" : "Colloids Surf B Biointerfaces",
      "citeRegEx" : "Liang et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Liang et al\\.",
      "year" : 2015
    }, {
      "title" : "Triptorelin 6-month formulation in the management of patients with locally advanced and metastatic prostate cancer: an open-label, non-comparative, multicentre, phase III study",
      "author" : [ "L. Goedhals", "D.G. Steyn", "C.F. Heyns", "L.A. Aldera", "T.M. Mackenzie", "D. Purcea", "P.Y. Grosgurin", "H.C. Porchet" ],
      "venue" : "Clinical drug investigation",
      "citeRegEx" : "Goedhals et al\\.,? \\Q2009\\E",
      "shortCiteRegEx" : "Goedhals et al\\.",
      "year" : 2009
    }, {
      "title" : "Cellular uptake and transport of zein nanoparticles: effects of sodium caseinate",
      "author" : [ "Y. Luo", "Z. Teng", "T.T. Wang", "Q. Wang" ],
      "venue" : "J Agric Food Chem",
      "citeRegEx" : "Luo et al\\.,? \\Q2013\\E",
      "shortCiteRegEx" : "Luo et al\\.",
      "year" : 2013
    }, {
      "title" : "zein/carboxymethyl chitosan nanoparticles with controlled release property and improved stability",
      "author" : [ "A. Masotti", "G. Ortaggi" ],
      "venue" : "Food Chem",
      "citeRegEx" : "Masotti and Ortaggi,? \\Q2009\\E",
      "shortCiteRegEx" : "Masotti and Ortaggi",
      "year" : 2009
    }, {
      "title" : "Three-dimensional structure of maize alpha-zein proteins studied by small-angle X-ray scattering. Biochimica et biophysica acta",
      "author" : [ "N. Matsushima", "G. Danno", "H. Takezawa", "Y. Izumi" ],
      "venue" : "Pure Appl. Chem",
      "citeRegEx" : "Matsushima et al\\.,? \\Q1997\\E",
      "shortCiteRegEx" : "Matsushima et al\\.",
      "year" : 1997
    }, {
      "title" : "proteins, and application to enzyme crosslinking",
      "author" : [ "F.A. Momany", "D.J. Sessa", "J.W. Lawton", "G.W. Selling", "S.A. Hamaker", "J.L. Willett" ],
      "venue" : "BioTechniques",
      "citeRegEx" : "Momany et al\\.,? \\Q2006\\E",
      "shortCiteRegEx" : "Momany et al\\.",
      "year" : 2006
    }, {
      "title" : "Preparation and Characterization of Zein and Zein-Chitosan Microspheres with Great Prospective of Application in Controlled Drug Release",
      "author" : [ "V. Muller", "J.F. Piai", "A.R. Fajardo", "S.L. Favaro", "A.F. Rubira", "E.C. Muniz" ],
      "venue" : "J Nanomater. Muthuselvi, L., Dhathathreyan,",
      "citeRegEx" : "Muller et al\\.,? \\Q2011\\E",
      "shortCiteRegEx" : "Muller et al\\.",
      "year" : 2011
    }, {
      "title" : "particles: From the nanometer to submicrometer size ranges",
      "author" : [ "R. Paliwal", "S. Palakurthi" ],
      "venue" : "Adv Powder Technol 22,",
      "citeRegEx" : "Paliwal and Palakurthi,? \\Q2014\\E",
      "shortCiteRegEx" : "Paliwal and Palakurthi",
      "year" : 2014
    }, {
      "title" : "Synthesis and characterisation of zein–curcumin colloidal particles",
      "author" : [ "A.R. Patel", "Y. Hu", "J.K. Tiwari", "K.P. Velikov" ],
      "venue" : "Soft Matter.,",
      "citeRegEx" : "Patel et al\\.,? \\Q2010\\E",
      "shortCiteRegEx" : "Patel et al\\.",
      "year" : 2010
    }, {
      "title" : "Method of forming non-immunogenic hydrophobic protein nanoparticles and uses therefor",
      "author" : [ "O. Perumal", "S. Podaralla", "R. Kaushik" ],
      "venue" : "South Dakota State University,",
      "citeRegEx" : "Perumal et al\\.,? \\Q2009\\E",
      "shortCiteRegEx" : "Perumal et al\\.",
      "year" : 2009
    }, {
      "title" : "Influence of formulation factors on the preparation of zein nanoparticles",
      "author" : [ "S. 312-317. Podaralla", "O. Perumal" ],
      "venue" : "AAPS PharmSciTech",
      "citeRegEx" : "Podaralla and Perumal,? \\Q2012\\E",
      "shortCiteRegEx" : "Podaralla and Perumal",
      "year" : 2012
    }, {
      "title" : "Production of alginate beads by emulsification/internal gelation",
      "author" : [ "D. Poncelet", "B. Poncelet De Smet", "C. Beaulieu", "M.L. Huguet", "A. Fournier", "R.J. Neufeld" ],
      "venue" : "II. Physicochemistry. Appl Microbiol Biotechnol",
      "citeRegEx" : "Poncelet et al\\.,? \\Q1995\\E",
      "shortCiteRegEx" : "Poncelet et al\\.",
      "year" : 1995
    }, {
      "title" : "Zein: the industrial protein from corn",
      "author" : [ "S. Rishi", "C. Munir" ],
      "venue" : "Industrial Crops and Products",
      "citeRegEx" : "Rishi and Munir,? \\Q2001\\E",
      "shortCiteRegEx" : "Rishi and Munir",
      "year" : 2001
    }, {
      "title" : "self-assembled monolayers: the effect of surface chemistry",
      "author" : [ "F.F. Sousa", "A. Luzardo-Alvarez", "J. Blanco-Mendez", "M. Martin-Pastor" ],
      "venue" : "Journal of biomedical materials research",
      "citeRegEx" : "Sousa et al\\.,? \\Q2012\\E",
      "shortCiteRegEx" : "Sousa et al\\.",
      "year" : 2012
    }, {
      "title" : "Interfacial turbulence: Hydrodynamic instability and the marangoni effect",
      "author" : [ "C.V. Sternling", "L.E. Scriven" ],
      "venue" : "AIChE Journal",
      "citeRegEx" : "Sternling and Scriven,? \\Q1959\\E",
      "shortCiteRegEx" : "Sternling and Scriven",
      "year" : 1959
    }, {
      "title" : "drugs available for selective cancer chemotherapy and development of a simple colorimetric determination of drugs in microspheres",
      "author" : [ "A.S. Tatham", "J.M. Field", "V.J. Morris", "K.J. I'Anson", "L. Cardle", "M.J. Dufton", "P.R. Shewry" ],
      "venue" : "BioEssays : news and reviews in molecular,",
      "citeRegEx" : "Tatham et al\\.,? \\Q1993\\E",
      "shortCiteRegEx" : "Tatham et al\\.",
      "year" : 1993
    }, {
      "title" : "cellular and developmental biology",
      "author" : [ "R. Vehring" ],
      "venue" : "Journal of pharmaceutical sciences 103,",
      "citeRegEx" : "Vehring,? \\Q2008\\E",
      "shortCiteRegEx" : "Vehring",
      "year" : 2008
    }, {
      "title" : "Fabrication and Characterization of Antioxidant Pickering Emulsions Stabilized by Zein/Chitosan Complex Particles (ZCPs)",
      "author" : [ "L.J. Wang", "Y.Q. Hu", "S.W. Yin", "X.Q. Yang", "F.R. Lai", "S.Q. Wang" ],
      "venue" : "Colloids Surf B Biointerfaces",
      "citeRegEx" : "Wang et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Wang et al\\.",
      "year" : 2015
    }, {
      "title" : "Topography and biocompatibility of patterned hydrophobic/hydrophilic zein layers",
      "author" : [ "Q. Wang", "W. Xian", "S. Li", "C. Liu", "G.W. Padua" ],
      "venue" : "Acta biomaterialia",
      "citeRegEx" : "Wang et al\\.,? \\Q2008\\E",
      "shortCiteRegEx" : "Wang et al\\.",
      "year" : 2008
    }, {
      "title" : "Amphiphilic zein hydrolysate as a novel nano-delivery vehicle for curcumin",
      "author" : [ "Y.H. Wang", "J.M. Wang", "X.Q. Yang", "J. Guo", "Y. Lin" ],
      "venue" : "Food & function",
      "citeRegEx" : "Wang et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Wang et al\\.",
      "year" : 2015
    }, {
      "title" : "Antioxidant and antimicrobial properties of essential oils encapsulated in zein nanoparticles prepared by liquid-liquid dispersion method",
      "author" : [ "Y.P. Wu", "Y.G. Luo", "Q. Wang" ],
      "venue" : "Plant physiology",
      "citeRegEx" : "Wu et al\\.,? \\Q2012\\E",
      "shortCiteRegEx" : "Wu et al\\.",
      "year" : 2012
    }, {
      "title" : "Controlled delivery of hollow corn protein nanoparticles via non-toxic crosslinking: in vivo and drug loading study",
      "author" : [ "H. Xu", "L. Shen", "L. Xu", "Y. Yang" ],
      "venue" : "Biomedical microdevices 17,",
      "citeRegEx" : "Xu et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Xu et al\\.",
      "year" : 2015
    }, {
      "title" : "delivery: Origin, classes and current landscape",
      "author" : [ "Y. Zhang", "L.L. Cui", "Y. Chen", "H. Zhang", "J. Zhong", "Y.N. Sun", "N.Q. Shi", "C.L. Li", "W. Kong" ],
      "venue" : "J Control Release",
      "citeRegEx" : "Zhang et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Zhang et al\\.",
      "year" : 2014
    }, {
      "title" : "pH-responsive drug delivery system based on coordination bonding in a mesostructured surfactant/silica hybrid",
      "author" : [ "H. 269-275. Zheng", "C. Gao", "B. Peng", "M. Shu", "S. Che" ],
      "venue" : "The Journal of Physical Chemistry C",
      "citeRegEx" : "Zheng et al\\.,? \\Q2011\\E",
      "shortCiteRegEx" : "Zheng et al\\.",
      "year" : 2011
    }, {
      "title" : "Zein nanoparticles produced by liquid–liquid dispersion",
      "author" : [ "Q. Zhong", "M. Jin" ],
      "venue" : "Food Hydrocolloid",
      "citeRegEx" : "Zhong and Jin,? \\Q2009\\E",
      "shortCiteRegEx" : "Zhong and Jin",
      "year" : 2009
    }, {
      "title" : "Encapsulation of Fish Oil in Solid Zein Particles by Liquid-Liquid Dispersion",
      "author" : [ "Q.X. Zhong", "H.L. Tian", "S. Zivanovic" ],
      "venue" : "J Food Process Pres",
      "citeRegEx" : "Zhong et al\\.,? \\Q2009\\E",
      "shortCiteRegEx" : "Zhong et al\\.",
      "year" : 2009
    } ],
    "referenceMentions" : [ {
      "referenceID" : 36,
      "context" : "Details of the amino acid composition, extraction and purification methods and physicochemical properties of zein can be found in other publications (John, 2002; Rishi and Munir, 2001).",
      "startOffset" : 149,
      "endOffset" : 184
    }, {
      "referenceID" : 2,
      "context" : "γ-zein contains 33% α-helix and 31% β-sheet in its physiological states (Bicudo et al., 2005).",
      "startOffset" : 72,
      "endOffset" : 93
    }, {
      "referenceID" : 2,
      "context" : "However, in the presence of reducing agent dithiothreitol, γ-zein displays an increased α-helix content of about 55% accompanied by a decrease in β-sheet content to 6% (Bicudo et al., 2008; Bicudo et al., 2005).",
      "startOffset" : 168,
      "endOffset" : 210
    }, {
      "referenceID" : 12,
      "context" : "This proline-rich hexapeptide is a type of cell-penetrating peptides, which could be used as a carrier to improve the cellular uptake of drugs and genes (Fernandez-Carneado et al., 2004).",
      "startOffset" : 153,
      "endOffset" : 186
    }, {
      "referenceID" : 39,
      "context" : "8 contrary to the elongated asymmetric structure determined by various physical measurements (Tatham et al., 1993).",
      "startOffset" : 93,
      "endOffset" : 114
    }, {
      "referenceID" : 28,
      "context" : "2 × 3 nm and an axial ratio of about 6:1 (Figure 1-b), which also consists of 9-10 adjacent and topologically antiparallel helices (Matsushima et al., 1997).",
      "startOffset" : 131,
      "endOffset" : 156
    }, {
      "referenceID" : 13,
      "context" : "according to the NMR, SAXS and FTIR data (Figure 1-c) (Forato et al., 2004).",
      "startOffset" : 54,
      "endOffset" : 75
    }, {
      "referenceID" : 29,
      "context" : "composed of three antiparallel helical segments linked by a glutamine-rich turn (Figure 1-d) (Momany et al., 2006).",
      "startOffset" : 93,
      "endOffset" : 114
    }, {
      "referenceID" : 21,
      "context" : "Similarly, another γ-zein of 27-kDa was reported to withstand pepsin digestion and to raise an immunogenic response in maize protein-allergic piglets and patients (Krishnan et al., 2011; Krishnan et al., 2010).",
      "startOffset" : 163,
      "endOffset" : 209
    }, {
      "referenceID" : 4,
      "context" : "disease suggested that zein or its digestion products may be presented by antigen-presenting cells to induce an immune response in these celiac patients (Cabrera-Chavez et al., 2012; Cabrera-Chavez et al., 2009).",
      "startOffset" : 153,
      "endOffset" : 211
    }, {
      "referenceID" : 33,
      "context" : "recent patent reported that zein nanoparticles of 100-400 nm were non-immunogenic, whereas zein nanoparticles with a size larger than 400 nm elicited a significant immune response in mice after the third and fifth weeks of primary and booster immunization via subcutaneous injection (Perumal et al., 2009).",
      "startOffset" : 283,
      "endOffset" : 305
    }, {
      "referenceID" : 46,
      "context" : "mono-dispersion by tailoring the surface properties of particles (Luo et al., 2012; Luo et al., 2011; Luo et al., 2013b; Zhang et al., 2014; Zou and Gu, 2013).",
      "startOffset" : 65,
      "endOffset" : 158
    }, {
      "referenceID" : 0,
      "context" : ", sodium caseinate and d-α-tocopheryl polyethylene glycol 1000 succinate [TPGS]) are reported to enhance the membrane permeability of zein nanoparticles and thus the oral bioavailability of loaded drugs (Ahmed et al., 2015; Luo et al., 2013a; Zou and Gu, 2013).",
      "startOffset" : 203,
      "endOffset" : 260
    }, {
      "referenceID" : 20,
      "context" : ", 1989), emulsification/solvent evaporation (Karthikeyan et al., 2012; Karthikeyan et al., 2014), spray drying (Chen and Zhong, 2014; de Sousa et al.",
      "startOffset" : 44,
      "endOffset" : 96
    }, {
      "referenceID" : 45,
      "context" : "Here, nano/microcapsules refer to a vesicular system with a distinct shell and a core-forming space that can entrap drugs (Xiao et al., 2011; Xu et al., 2015; Xu et al., 2011).",
      "startOffset" : 122,
      "endOffset" : 175
    }, {
      "referenceID" : 45,
      "context" : "The resultant nanocapsules show a similar morphology to zein nanoparticles and have a size of less than 100 nm (Xu et al., 2015; Xu et al., 2011).",
      "startOffset" : 111,
      "endOffset" : 145
    }, {
      "referenceID" : 6,
      "context" : "conventional surfactants (Aveyard et al., 2003; Chevalier and Bolzinger, 2013), and it usually displays a core-shell structure with large size, as shown in Figure 2.",
      "startOffset" : 25,
      "endOffset" : 78
    }, {
      "referenceID" : 14,
      "context" : "wettability of zein particles by introducing other ingredients, such as sodium stearate, chitosan and tannic acid (Gao et al., 2014; Wang et al., 2015a; Zou et al., 2015).",
      "startOffset" : 114,
      "endOffset" : 170
    }, {
      "referenceID" : 14,
      "context" : "Some of these ingredients can induce conformational changes of zein molecules to varying extents and confer the particles with higher adaptability (probably more appropriate particle size and contact angle) at the oil-water interface, thus leading to a greater emulsion stability (Gao et al., 2014; Zou et al., 2015).",
      "startOffset" : 280,
      "endOffset" : 316
    }, {
      "referenceID" : 20,
      "context" : "This method can be used to encapsulate hydrophobic, amphiphilic and hydrophilic drugs (Karthikeyan et al., 2014).",
      "startOffset" : 86,
      "endOffset" : 112
    }, {
      "referenceID" : 20,
      "context" : "hydrophilic > amphiphilic, which is closely related to the binding affinity of the drugs with zein (Karthikeyan et al., 2014).",
      "startOffset" : 99,
      "endOffset" : 125
    }, {
      "referenceID" : 35,
      "context" : "The mechanism of internal gelation is based on oil-soluble acid-initiated calcium ion release and calcium ion-mediated polymer crosslinking (Poncelet et al., 1992; Poncelet et al., 1995).",
      "startOffset" : 140,
      "endOffset" : 186
    }, {
      "referenceID" : 40,
      "context" : "The particle size can be adjusted by the original solute concentration in feed liquid and the droplet size of the atomized liquid (Vehring, 2008).",
      "startOffset" : 130,
      "endOffset" : 145
    }, {
      "referenceID" : 40,
      "context" : "significantly affect the morphology of the resulting particles (Vehring, 2008).",
      "startOffset" : 63,
      "endOffset" : 78
    }, {
      "referenceID" : 40,
      "context" : "As for detailed information and related equations proposed to estimate how the above factors influence particle size and morphology, the reader is referred to the published works (Nandiyanto and Okuyama, 2011; Vehring, 2008; Walters et al., 2014; Wang et al., 2008b).",
      "startOffset" : 179,
      "endOffset" : 266
    }, {
      "referenceID" : 40,
      "context" : "the differential mass and heat transfer of the droplet during the spray-drying process (Vehring, 2008).",
      "startOffset" : 87,
      "endOffset" : 102
    }, {
      "referenceID" : 37,
      "context" : "Hydrophobic drugs usually have higher encapsulation efficiency and slower release profile than hydrophilic drugs, which strongly correlates to the molecular affinity of the drugs with zein as evidenced by NMR analyses (Sousa et al., 2012; Sousa et al., 2010).",
      "startOffset" : 218,
      "endOffset" : 258
    }, {
      "referenceID" : 1,
      "context" : "in which small particles dissolve and redeposit onto larger particles (Aubry et al., 2009; Kahlweit, 1975).",
      "startOffset" : 70,
      "endOffset" : 106
    }, {
      "referenceID" : 19,
      "context" : "in which small particles dissolve and redeposit onto larger particles (Aubry et al., 2009; Kahlweit, 1975).",
      "startOffset" : 70,
      "endOffset" : 106
    }, {
      "referenceID" : 1,
      "context" : "However, in the case of a high zein concentration and thus a large number of nuclei, the growth of the nuclei is expected to occur mainly through random collisions of existing particles (Aubry et al., 2009).",
      "startOffset" : 186,
      "endOffset" : 206
    }, {
      "referenceID" : 38,
      "context" : "In addition, nucleation and nucleus growth may be influenced by interfacial turbulence occurring during mixing (Sternling and Scriven, 1959).",
      "startOffset" : 111,
      "endOffset" : 140
    }, {
      "referenceID" : 45,
      "context" : "nuclei can produce hollow zein nanoparticles (namely nanocapsules) (Xu et al., 2015; Xu et al., 2011).",
      "startOffset" : 67,
      "endOffset" : 101
    }, {
      "referenceID" : 34,
      "context" : "26 droplets breakup, zein nucleation and collision-induced nucleus growth (Podaralla and Perumal, 2012; Zhong and Jin, 2009b).",
      "startOffset" : 74,
      "endOffset" : 125
    }, {
      "referenceID" : 16,
      "context" : "massive nuclei, whereas low supersaturation leads to few stable nuclei (Horn and Rieger, 2001).",
      "startOffset" : 71,
      "endOffset" : 94
    }, {
      "referenceID" : 36,
      "context" : "The aggregation tendency of zein colloidal systems at near neutral pH or high ionic strength is because of diminished electrostatic repulsion and increased hydrophobic interactions (Rishi and Munir, 2001).",
      "startOffset" : 181,
      "endOffset" : 204
    }, {
      "referenceID" : 5,
      "context" : ", 2010b), β-lactoglobulin (Chen et al., 2014), pectin (Hu et al.",
      "startOffset" : 26,
      "endOffset" : 45
    }, {
      "referenceID" : 44,
      "context" : "However, zein-based carriers may aggregate during freeze-drying process due to hydrophobic interactions or the physical entanglement of polymer chains even in the presence of stabilizers (Wu et al., 2012).",
      "startOffset" : 187,
      "endOffset" : 204
    }, {
      "referenceID" : 18,
      "context" : "Lyoprotectant mannitol is known to have the ability to form supporting structure for particles by crystallization during the slow drying process, whereas trehalose can replace water molecules around particles and to remain their spatial structure via bulk hydrogen bond interactions (Jain and Roy, 2009).",
      "startOffset" : 283,
      "endOffset" : 303
    }, {
      "referenceID" : 34,
      "context" : "However, citrate buffer was found to be more effective in preventing particles from aggregation than phosphate buffer due to citric acid-mediated amino group crosslinking and resistance to pH change during lyophilization (Podaralla and Perumal, 2012).",
      "startOffset" : 221,
      "endOffset" : 250
    }, {
      "referenceID" : 15,
      "context" : ", tablets and inserts) made from zein microparticles are also introduced here to illustrate their potential as the foundation for future medical practices (de Sousa et al., 2012; Gong et al., 2011; Liu et al., 2005).",
      "startOffset" : 155,
      "endOffset" : 215
    }, {
      "referenceID" : 15,
      "context" : "The subsequent pharmacokinetics analysis using dogs revealed a longer plasma mean residence time of up to 55 h (Gong et al., 2011).",
      "startOffset" : 111,
      "endOffset" : 130
    }, {
      "referenceID" : 24,
      "context" : "More recently, pH-sensitive zein nanoparticles using metal-tannic acid (TA) films as coating materials were developed (Liang et al., 2015).",
      "startOffset" : 118,
      "endOffset" : 138
    }, {
      "referenceID" : 47,
      "context" : "The mechanisms underlying the controlled release is low pH-mediated cleavage of metal-tannic acid coordination bonds and therefore the disassembly of metaltannic acid films (Zheng et al., 2011).",
      "startOffset" : 173,
      "endOffset" : 193
    }, {
      "referenceID" : 24,
      "context" : "Strong coordination bonding will diminish the pH responsibility of the coated zein nanoparticles (Liang et al., 2015).",
      "startOffset" : 97,
      "endOffset" : 117
    }, {
      "referenceID" : 10,
      "context" : ", 2010b), abamectin (Demchak and Dybas, 1997) and fish oil (Zhong et al.",
      "startOffset" : 20,
      "endOffset" : 45
    }, {
      "referenceID" : 45,
      "context" : "40 nanocapsules with the a size less than 100 nm also displayed a liver-targeting effect following intravenous injection in mice (Xu et al., 2015).",
      "startOffset" : 129,
      "endOffset" : 146
    }, {
      "referenceID" : 45,
      "context" : "In contrast, citric acid-crosslinked zein nanocapsules preferentially targeted the kidneys and showed a prolonged residence time (Figure 13) (Xu et al., 2015).",
      "startOffset" : 141,
      "endOffset" : 158
    }, {
      "referenceID" : 15,
      "context" : "In addition to zein-based nanoparticles, PEG-zein micelles and tableted zein microparticles were reported to enhance the cellular uptake and oral bioavailability of encapsulated agents, respectively (Gong et al., 2011; Podaralla et al., 2012).",
      "startOffset" : 199,
      "endOffset" : 242
    }, {
      "referenceID" : 0,
      "context" : ", oral bioavailability) than the commercially available products (Ahmed et al., 2015; Gong et al., 2011; Hashem et al., 2015).",
      "startOffset" : 65,
      "endOffset" : 125
    }, {
      "referenceID" : 15,
      "context" : ", oral bioavailability) than the commercially available products (Ahmed et al., 2015; Gong et al., 2011; Hashem et al., 2015).",
      "startOffset" : 65,
      "endOffset" : 125
    } ],
    "year" : 2016,
    "abstractText" : null,
    "creator" : "Elsevier"
  }
}